10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

Form 10-Q

 (Mark One)

☒      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

☐         TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

FOR THE TRANSITION PERIOD FROM                   TO                   .

Commission file number 001-14775

 DMC GLOBAL INC.

(Exact name of Registrant as Specified in its Charter)

Delaware	84-0608431
(State of Incorporation or Organization)	(I.R.S. Employer Identification No.)

11800 Ridge Parkway, Suite 300, Broomfield, Colorado 80021

(Address of principal executive offices, including zip code)

(303) 665-5700

(Registrant’s telephone number, including area code)

Title of each class	Trading Symbol	Name of exchange on which registered
Common Stock, $0.05 Par Value	BOOM	The Nasdaq Global Select Market

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒  No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☒  No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange

Act. 

Large accelerated filer ☐	Accelerated filer ☒
Non-accelerated filer ☐	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 under the Act).  Yes  ☐  No ☒

The number of shares of Common Stock outstanding was 18,724,831 as of October 21, 2021.

CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934. We intend the forward-looking statements throughout this quarterly report on Form 10-Q to be covered by the safe harbor provisions for forward-looking statements. Statements contained in this report which are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from projected results. These statements can sometimes be identified by our use of forward-looking words such as “may,” “believe,” “plan,” “anticipate,” “estimate,” “expect,” “intend,” and other phrases of similar meaning. Such statements include expectations regarding improvements to DynaEnergetics’ end markets, planned price increases at DynaEnergetics, our ability to access our ATM in the future, our expected use of proceeds from equity offerings, expected continuing litigation costs, expected material and labor cost trends, the timing of shipment and financial impacts of NobelClad’s large titanium clad plate order received in the second quarter of 2021, the impacts of seasonality on DynaEnergetics’ business in the fourth quarter of 2021, our ability to claim the Employee Retention Credit (“ERC”) under the Coronavirus Aid, Relief, and Economic Security Act, as amended, and the availability of funds to support our liquidity position and our expected future liquidity position. The forward-looking information is based on information available as of the date of this quarterly report and on numerous assumptions and developments that are not within our control. Although we believe that our expectations as expressed in these forward-looking statements are reasonable, we cannot assure you that our expectations will turn out to be correct. Factors that could cause actual results to differ materially include, but are not limited to, those factors referenced in our Annual Report on Form 10-K for the year ended December 31, 2020 and such things as the following: impacts of COVID-19 and any related preventative or protective actions taken by governmental authorities and resulting economic impacts, including recessions or depressions; supply chain delays and disruptions; transportation disruptions; the ability to obtain new contracts at attractive prices; the size and timing of customer orders and shipments; product pricing and margins; our ability to realize sales from our backlog; fluctuations in customer demand; fluctuations in foreign currencies; competitive factors; the timely completion of contracts; the timing and size of expenditures; the timely receipt of government approvals and permits; the price and availability of metal and other raw material; fluctuations in tariffs or quotas; changes in laws and regulations, both domestic and foreign, impacting our business and the business of the end-market users we serve; the adequacy of local labor supplies at our facilities; current or future limits on manufacturing capacity at our various operations; our ability to successfully integrate acquired businesses; the impact of pending or future litigation or regulatory matters; the availability and cost of funds; our ability to access our borrowing capacity under our credit facility or access the capital markets; and global economic conditions and political and economic developments. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We undertake no obligation to publicly release the results of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

INDEX

 

		Page
PART I - FINANCIAL INFORMATION
Item 1	Condensed Consolidated Financial Statements	4
	Condensed Consolidated Balance Sheets as of September 30, 2021 (unaudited) and December 31, 2020	4
	Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020 (unaudited)	5
	Condensed Consolidated Statements of Comprehensive (Loss) Income for the three and nine months ended September 30, 2021 and 2020 (unaudited)	6
	Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2021 and 2020 (unaudited)	7
	Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020 (unaudited)	9
	Notes to Condensed Consolidated Financial Statements (unaudited)	10
Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3	Quantitative and Qualitative Disclosure about Market Risk	37
Item 4	Controls and Procedures	38
PART II - OTHER INFORMATION
Item 1	Legal Proceedings	39
Item 1A	Risk Factors	39
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	39
Item 3	Defaults Upon Senior Securities	39
Item 4	Mine Safety Disclosures	39
Item 5	Other Information	40
Item 6	Exhibits	40
	Signatures	40

3

Part I - FINANCIAL INFORMATION

ITEM 1.  Condensed Consolidated Financial Statements

DMC GLOBAL INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in Thousands, Except Share and Per Share Data)

	September 30, 2021		December 31, 2020
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	37,020	$	28,187
Marketable securities	144,932		25,736
Accounts receivable, net of allowance for doubtful accounts of $2,693 and $2,605, respectively	39,347		31,366
Inventories	62,172		52,573
Prepaid expenses and other	9,974		5,448
Total current assets	293,445		143,310
Property, plant and equipment	172,039		180,278
Less - accumulated depreciation	(66,902)		(70,867)
Property, plant and equipment, net	105,137		109,411
Purchased intangible assets, net	1,829		3,665
Deferred tax assets	5,747		4,582
Other assets	30,217		18,677
Total assets	$	436,375	$	279,645
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	24,436	$	17,574
Accrued expenses	7,459		5,301
Accrued income taxes	8,101		7,279
Accrued employee compensation and benefits	8,585		7,160
Contract liabilities	9,759		4,928
Current portion of long-term debt	—		3,125
Other current liabilities	1,648		1,741
Total current liabilities	59,988		47,108
Long-term debt	—		8,139
Deferred tax liabilities	1,373		2,254
Other long-term liabilities	30,114		25,230
Total liabilities	91,475		82,731
Commitments and contingencies (Note 12)
Stockholders’ equity
Preferred stock, $0.05 par value; 4,000,000 shares authorized; no issued and outstanding shares	—		—
Common stock, $0.05 par value; 25,000,000 shares authorized; 19,294,745 and 15,917,559 shares issued, respectively	965		796
Additional paid-in capital	270,993		117,387
Retained earnings	118,216		115,657
Other cumulative comprehensive loss	(25,803)		(22,962)
Treasury stock, at cost, and company stock held for deferred compensation, at par; 569,914 and 528,274 shares, respectively	(19,471)		(13,964)
Total stockholders’ equity	344,900		196,914
Total liabilities and stockholders’ equity	$	436,375	$	279,645

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

4

DMC GLOBAL INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in Thousands, Except Share and Per Share Data)

(unaudited)

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales	$	67,175	$	55,281	$	188,271	$	172,048
Cost of products sold	50,513		41,688		141,725		127,381
Gross profit	16,662		13,593		46,546		44,667
Costs and expenses:
General and administrative expenses	9,721		6,911		26,121		21,744
Selling and distribution expenses	5,593		4,705		16,380		18,720
Amortization of purchased intangible assets	211		369		823		1,076
Restructuring expenses and asset impairments	—		143		127		3,305
Total costs and expenses	15,525		12,128		43,451		44,845
Operating income (loss)	1,137		1,465		3,095		(178)
Other income (expense):
Other (expense) income, net	(198)		(148)		304		(118)
Interest expense, net	(14)		(170)		(230)		(564)
Income (loss) before income taxes	925		1,147		3,169		(860)
Income tax provision (benefit)	522		139		610		(375)
Net income (loss)	$	403	$	1,008	$	2,559	$	(485)
Net income (loss) per share
Basic	$	0.02	$	0.07	$	0.15	$	(0.03)
Diluted	$	0.02	$	0.07	$	0.15	$	(0.03)
Weighted average shares outstanding:
Basic	18,728,278		14,820,881		17,239,306		14,759,062
Diluted	18,739,085		14,820,881		17,250,525		14,759,062
Dividends declared per common share	$	—	$	—	$	—	$	0.125

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

5

DMC GLOBAL INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(Amounts in Thousands)

(unaudited)

 

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net income (loss)	$	403	$	1,008	$	2,559	$	(485)
Change in cumulative foreign currency translation adjustment	(1,347)		753		(2,841)		518
Total comprehensive (loss) income	$	(944)	$	1,761	$	(282)	$	33

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

6

DMC GLOBAL INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Amounts in Thousands, Except Share Data)

(unaudited)

								Other		Treasury Stock and
				Additional				Cumulative		Company Stock Held for
	Common Stock			Paid-In		Retained		Comprehensive		Deferred Compensation
	Shares	Amount		Capital		Earnings		Loss		Shares	Amount		Total
Balances, June 30, 2021	19,294,745	$	965	$	269,375	$	117,813	$	(24,456)	(569,737)	$	(17,660)	$	346,037
Net income	—	—		—		403		—		—	—		403
Change in cumulative foreign currency translation adjustment	—	—		—		—		(1,347)		—	—		(1,347)
Stock-based compensation	—	—		1,618		—		—		—	—		1,618
Treasury stock activity	—	—		—		—		—		(177)	(1,811)		(1,811)
Balances, September 30, 2021	19,294,745	$	965	$	270,993	$	118,216	$	(25,803)	(569,914)	$	(19,471)	$	344,900

								Other		Treasury Stock and
				Additional				Cumulative		Company Stock Held for
	Common Stock			Paid-In		Retained		Comprehensive		Deferred Compensation
	Shares	Amount		Capital		Earnings		Loss		Shares	Amount		Total
Balances, June 30, 2020	15,297,291	$	765	$	88,501	$	115,576	$	(26,038)	(527,981)	$	(8,521)	$	170,283
Net income	—	—		—		1,008		—		—	—		1,008
Change in cumulative foreign currency translation adjustment	—	—		—		—		753		—	—		753
Shares issued in connection with stock compensation plans	2,933	—		3		—		—		—	—		3
Stock-based compensation	—	—		1,554		—		—		—	—		1,554
Treasury stock activity	—	—		11		—		—		(56)	(3,661)		(3,650)
Balances, September 30, 2020	15,300,224	$	765	$	90,069	$	116,584	$	(25,285)	(528,037)	$	(12,182)	$	169,951

7

DMC GLOBAL INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Amounts in Thousands, Except Share Data)

(unaudited)

								Other		Treasury Stock and
				Additional				Cumulative		Company Stock Held for
	Common Stock			Paid-In		Retained		Comprehensive		Deferred Compensation
	Shares	Amount		Capital		Earnings		Loss		Shares	Amount		Total
Balances, December 31, 2020	15,917,559	$	796	$	117,387	$	115,657	$	(22,962)	(528,274)	$	(13,964)	$	196,914
Net income	—	—		—		2,559		—		—	—		2,559
Change in cumulative foreign currency translation adjustment	—	—		—		—		(2,841)		—	—		(2,841)
Shares issued in connection with equity offering	2,875,000	144		123,317		—		—		—	—		123,461
Shares issued in connection with at-the-market offering program	397,820	20		25,242		—		—		—	—		25,262
Shares issued in connection with stock compensation plans	104,366	5		248		—		—		—	—		253
Stock-based compensation	—	—		4,799		—		—		—	—		4,799
Treasury stock activity	—	—		—		—		—		(41,640)	(5,507)		(5,507)
Balances, September 30, 2021	19,294,745	$	965	$	270,993	$	118,216	$	(25,803)	(569,914)	$	(19,471)	$	344,900

								Other		Treasury Stock and
				Additional				Cumulative		Company Stock Held for
	Common Stock			Paid-In		Retained		Comprehensive		Deferred Compensation
	Shares	Amount		Capital		Earnings		Loss		Shares	Amount		Total
Balances, December 31, 2019	15,117,207	$	756	$	85,639	$	119,002	$	(25,803)	(464,532)	(7,453)		$	172,141
Net loss	—	—		—		(485)		—		—	—		(485)
Change in cumulative foreign currency translation adjustment	—	—		—		—		518		—	—		518
Shares issued in connection with stock compensation plans	183,017	9		257		—		—		—	—		266
Adjustment for cumulative effect from change in accounting principle (ASU 2016-13)	—	—		—		(50)		—		—	—		(50)
Stock-based compensation	—	—		4,162		—		—		—	—		4,162
Dividends declared	—	—		—		(1,883)		—		—	—		(1,883)
Treasury stock activity	—	—		11		—		—		(63,505)	(4,729)		(4,718)
Balances, September 30, 2020	15,300,224	$	765	$	90,069	$	116,584	$	(25,285)	(528,037)	$	(12,182)	$	169,951

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements

8

DMC GLOBAL INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in Thousands)

(unaudited)

	Nine months ended September 30,
	2021		2020
Cash flows provided by operating activities:
Net income (loss)	$	2,559	$	(485)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation	8,400		7,167
Amortization of purchased intangible assets	823		1,076
Amortization of deferred debt issuance costs	168		154
Stock-based compensation	4,904		4,154
Deferred income taxes	(2,046)		(839)
(Gain) loss on disposal of property, plant and equipment	(298)		113
Restructuring expenses and asset impairments	127		3,305
Change in:
Accounts receivable, net	(8,562)		26,890
Inventories	(10,620)		(2,228)
Prepaid expenses and other	(15,892)		(2,855)
Accounts payable	6,861		(10,563)
Contract liabilities	4,957		2,376
Accrued expenses and other liabilities	6,713		(6,911)
Net cash (used in) provided by operating activities	(1,906)		21,354
Cash flows used in investing activities:
Investment in marketable securities	(123,984)		—
Proceeds from maturities of marketable securities	4,799		—
Acquisition of property, plant and equipment	(6,348)		(9,682)
Proceeds on sale of property, plant and equipment	1,019		20
Net cash used in investing activities	(124,514)		(9,662)
Cash flows provided by (used in) financing activities:
Repayments on capital expenditure facility	(11,750)		(2,344)
Payment of dividends	—		(3,749)
Payment of debt issuance costs	—		(88)
Net proceeds from issuance of common stock through equity offering	123,461		—
Net proceeds from issuance of common stock through at-the-market offering program	25,262		—
Net proceeds from issuance of common stock to employees and directors	253		266
Treasury stock purchases	(2,476)		(1,123)
Net cash provided by (used in) financing activities	134,750		(7,038)
Effects of exchange rates on cash	503		(403)
Net increase in cash and cash equivalents	8,833		4,251
Cash and cash equivalents, beginning of the period	28,187		20,353
Cash and cash equivalents, end of the period	$	37,020	$	24,604

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

9

DMC GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in Thousands, Except Share and Per Share Data)

(unaudited)

1.      BASIS OF PRESENTATION

The information included in the condensed consolidated financial statements is unaudited but includes all normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the interim periods presented. Certain information and footnote disclosures, including critical and significant accounting policies normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted for this quarterly presentation. These condensed consolidated financial statements should be read in conjunction with the financial statements that are included in our Annual Report filed on Form 10-K for the year ended December 31, 2020.

2.      SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The condensed consolidated financial statements include the accounts of DMC Global Inc. (“DMC”, “we”, “us”, “our”, or the “Company”) and its controlled subsidiaries. Only subsidiaries in which controlling interests are maintained are consolidated. All significant intercompany accounts, profits, and transactions have been eliminated in consolidation.

Marketable Securities

We typically invest in highly rated securities with the primary objectives of preserving principal, providing access to liquidity to fund the ongoing operations and strategic needs of the Company and its subsidiaries, and achieving a yield that is commensurate with low risk and highly liquid securities.

Our investments in marketable debt securities are classified as either trading, available-for-sale or held-to-maturity based on the nature of the securities and their availability for use in current operations. The Company classifies its marketable debt securities in the Condensed Consolidated Balance Sheet as current or non-current based on related maturities and expectations of sales and redemptions in the subsequent twelve-month period. The Company may sell certain of its marketable debt securities prior to their stated maturities to manage liquidity, credit risk, or asset allocation.

As of September 30, 2021 and December 31, 2020, our investments had maturities ranging from three to twelve months, and all such investments have been classified and accounted for as trading securities.

The Company’s investments in marketable securities consisted of the following:

	September 30, 2021		December 31, 2020
U.S. Treasury securities	$	76,591	$	25,736
Commercial paper (A-1 or P-1 rated)	68,341		—
Marketable securities	$	144,932	$	25,736

The Company’s U.S. Treasury securities have annual yields between 0.01% and 0.04% and the commercial paper securities have annual yields between 0.09% and 0.10%. The Company’s investments in marketable securities are measured at fair value with gains and losses recognized in the Condensed Consolidated Statement of Operations within “Other (expense) income, net." For the three and nine months ended September 30, 2021, the net gains on marketable securities were $2 and $12, respectively.

Accounts and Notes Receivable

The Company measures expected credit losses for its accounts receivable using a current expected credit loss model, which is based on historical experience, adjusted for current conditions and reasonable and supportable forecasts. The Company has disaggregated pools of accounts receivable balances by business, geography and/or customer risk profile and has used

10

history and other experience to establish an allowance for credit losses at the time the receivable is recognized. To measure expected credit losses, we have elected to pool trade receivables by segment and analyze DynaEnergetics and NobelClad accounts receivable balances as separate populations. Within each segment, receivables exhibit similar risk characteristics.

During the three and nine months ended September 30, 2021, our expected loss rate continued to reflect uncertainties in market conditions present in both of our businesses due to the ongoing COVID-19 pandemic. In addition, we reviewed receivables outstanding, including aged balances, and in circumstances where we are aware of a specific customer’s inability to meet its financial obligation to us, we recorded a specific allowance for credit losses (with the offsetting expense charged to “Selling and distribution expenses” in our Condensed Consolidated Statements of Operations) against the amounts due, reducing the net recognized receivable to the amount we estimate will be collected. During the three and nine months ended September 30, 2021, provisions of $4 and $100, respectively, were recorded.

The following table summarizes year-to-date activity in the allowance for credit losses on receivables from DynaEnergetics and NobelClad customers:

	DynaEnergetics		NobelClad		DMC Global Inc.
Allowance for doubtful accounts, December 31, 2020	$	2,590	$	15	$	2,605
Current period provision for expected credit losses	100		—		100
Recoveries of amounts previously reserved	(10)		—		(10)
Impacts of foreign currency exchange rates and other	(2)		—		(2)
Allowance for doubtful accounts, September 30, 2021	$	2,678	$	15	$	2,693

During the third quarter of 2021, the Company entered into a note receivable with terms of repayment over five years, collateralized by certain fixed assets. The note, with an outstanding current balance of $622 as of September 30, 2021 recorded within “Prepaid expenses and other” and an outstanding long-term balance of $4,995 as of September 30, 2021 recorded within “Other Assets”, is considered an arrangement with a variable interest entity for which the Company is not the primary beneficiary and has concluded does not require consolidation.

Revenue Recognition

The Company’s revenues are primarily derived from consideration paid by customers for tangible goods. The Company analyzes its different goods by segment to determine the appropriate basis for revenue recognition. Revenue is not generated from sources other than contracts with customers and revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. There are no material upfront costs for operations that are incurred from contracts with customers.

Our rights to payments for goods transferred to customers arise when control is transferred at a point in time and not on any other criteria. Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 60 days. In instances when we require customers to make advance payments prior to the shipment of their orders, we record a contract liability. We have determined that our contract liabilities do not include a significant financing component given the short duration between order initiation and order fulfillment within each of our segments. Please refer to Note 5 “Contract Liabilities” for further information on contract liabilities and Note 10 “Business Segments” for disaggregated revenue disclosures.

Income Taxes

We recognize deferred tax assets and liabilities for the expected future income tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities. Any effects of changes in income tax rates or tax laws are included in the provision for income taxes in the period of enactment. The deferred income tax impact of tax credits is recognized as an immediate adjustment to income tax expense. We recognize deferred tax assets for the expected future effects of all deductible temporary differences to the extent we believe these assets will more likely than not be realized. We record a valuation allowance when, based on current circumstances, it is more likely than not that all or a portion of the deferred tax assets will not be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, recent financial operations and their associated valuation allowances, if any.

11

We recognize the tax benefits from uncertain tax positions only when it is more likely than not, based on the technical merits of the position that it will be sustained upon examination, including the resolution of any related appeals or litigation. The tax benefits recognized in the consolidated financial statements from such a position are measured as the largest benefit that is more likely than not to be realized upon ultimate resolution. We recognize interest and penalties related to uncertain tax positions in operating expense.

Earnings Per Share

In periods with net income, the Company computes earnings per share (“EPS”) using a two-class method, which is an earnings allocation formula that determines EPS for (i) each class of common stock (the Company has a single class of common stock), and (ii) participating securities according to dividends declared and participation rights in undistributed earnings. Restricted stock awards are considered participating securities in periods of net income as they receive non-forfeitable rights to dividends similar to common stock. Restricted stock awards do not participate in net losses.

Basic EPS is calculated by dividing net income available to common stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS adjusts basic EPS for the effects of restricted stock awards, performance share units and other potentially dilutive financial instruments (dilutive securities), only in the periods in which such effect is dilutive. The effect of the dilutive securities is reflected in diluted EPS by application of the more dilutive of (1) the treasury stock method or (2) the two-class method. For the periods presented, diluted EPS using the treasury stock method was less dilutive than the two-class method; as such, only the two-class method has been included below.

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net income (loss), as reported	$	403	$	1,008	2,559		(485)
Less: Undistributed net income available to participating securities	(3)		(17)		(25)		—
Numerator for basic net income (loss) per share:	400		991		2,534		(485)
Add: Undistributed net income allocated to participating securities	3		17		25		—
Less: Undistributed net income reallocated to participating securities	(3)		(17)		(25)		—
Numerator for diluted net income (loss) per share:	400		991		2,534		(485)
Denominator:
Weighted average shares outstanding for basic net income (loss) per share	18,728,278		14,820,881		17,239,306		14,759,062
Effect of dilutive securities (1)	10,807		—		11,219		—
Weighted average shares outstanding for diluted net income (loss) per share	18,739,085		14,820,881		17,250,525		14,759,062
Net income (loss) per share
Basic	$	0.02	$	0.07	$	0.15	$	(0.03)
Diluted	$	0.02	$	0.07	$	0.15	$	(0.03)

(1) For the three and nine months ended September 30, 2020, 30,967 and 19,394 respectively, shares have been excluded as their effect would have been anti-dilutive.

Deferred compensation

The Company maintains a Non-Qualified Deferred Compensation Plan (the “Plan”) as part of its overall compensation package for certain employees. Participants are eligible to defer a portion of their annual salary, their annual incentive bonus, and their equity awards through the Plan on a tax-deferred basis. Deferrals into the Plan are not matched or subsidized by the Company, nor are they eligible for above-market or preferential earnings.

The Plan provides for deferred compensation obligations to be settled either by delivery of a fixed number of shares of DMC’s common stock or in cash, in accordance with participant contributions and elections. For deferred equity awards, subsequent to equity award vesting and after a period prescribed by the Plan, participants can elect to diversify contributions of equity awards into other investment options available to Plan participants. Once diversified, contributions of equity awards will be settled by delivery of cash.

12

The Company has established a grantor trust commonly known as a “rabbi trust” and contributed certain assets to satisfy the future obligations to participants in the Plan. These assets are subject to potential claims of the Company’s general creditors. The assets held in the trust include unvested restricted stock awards (“RSAs”), vested company stock awards, company-owned life insurance (“COLI”) on certain employees, and money market and mutual funds. Unvested RSAs and common stock held by the trust are reflected in the Consolidated Balance Sheets within “Treasury stock, at cost, and company stock held for deferred compensation, at par” at the par value of the common stock or unvested RSAs. These accounts are not adjusted for subsequent changes in the fair value of the common stock. COLI is accounted for at the cash surrender value while money market and mutual funds held by the trust are accounted for at fair value.

Deferred compensation obligations that will be settled in cash are accounted for on an accrual basis in accordance with the terms of the Plan. These obligations are adjusted based on changes in value of the underlying investment options chosen by Plan participants. Deferred compensation obligations that will be settled by delivery of a fixed number of previously vested shares of the Company’s common stock are reflected in the Consolidated Statements of Stockholders’ Equity within “Common stock” at the par value of the common stock or unvested RSAs. These accounts are not adjusted for subsequent changes in the fair value of the common stock.

The balances related to the deferred compensation plan were as follows:

	Consolidated Balance Sheet location	September 30, 2021		December 31, 2020
Deferred compensation assets	Other assets	$	13,261	$	7,596
Deferred compensation obligations	Other long-term liabilities	$	15,695	$	11,894

Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We are required to use an established hierarchy for fair value measurements based upon the inputs to the valuation and the degree to which they are observable or not observable in the market. The three levels in the hierarchy are as follows:                   

•Level 1 — Inputs to the valuation based upon quoted prices (unadjusted) for identical assets or liabilities in active markets that are accessible as of the measurement date.

•Level 2 — Inputs to the valuation include quoted prices in either markets that are not active, or in active markets for similar assets or liabilities, inputs other than quoted prices that are observable, and inputs that are derived principally from or corroborated by observable market data.

•Level 3 — Inputs to the valuation that are unobservable inputs for the asset or liability. 

The highest priority is assigned to Level 1 inputs and the lowest priority to Level 3 inputs.

The carrying value of accounts receivable and payable, accrued expenses, revolving loans under our credit facility and borrowings under our capital expenditure facility, when outstanding, approximate their fair value.

Our U.S. Treasury marketable securities are valued using quoted prices in active markets that are accessible as of the measurement date. Our revolving loans and borrowings under our capital expenditure facility, when outstanding, reset each month at market interest rates. Money market funds and mutual funds of $8,629 as of September 30, 2021 and $4,244 as of December 31, 2020 held to satisfy future deferred compensation obligations are valued based upon the market values of underlying securities. We classify these assets as Level 1 in the fair value hierarchy.

Our commercial paper marketable securities are valued using quoted market prices in non-active markets. Our foreign currency forward contracts are also valued using quoted market prices in non-active markets or are determined using a yield curve model based on current market rates. As a result, we classify commercial paper marketable securities and foreign currency forward contracts as Level 2 in the fair value hierarchy.

We did not hold any Level 3 assets or liabilities as of September 30, 2021 or December 31, 2020.

Recent Accounting Pronouncements

13

In December 2019, the Financial Accounting Standards Board issued a new accounting pronouncement regarding accounting for income taxes. The new standard removes certain exceptions to the general principles in ASC 740 Income Taxes and also clarifies and amends existing guidance to provide for more consistent application. The new standard became effective for the Company in the first quarter of fiscal 2021 and did not have a material impact on our consolidated financial statements.

3.      INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Significant cost elements included in inventory are material, labor, freight, subcontract costs, and manufacturing overhead. As necessary, we adjust inventory to its net realizable value by recording provisions for excess, slow moving and obsolete inventory. We regularly review inventory quantities on hand and values, and compare them to estimates of future product demand, market conditions, production requirements and technological developments.

Inventories consisted of the following at September 30, 2021:

	DynaEnergetics		NobelClad		DMC Global Inc.
Raw materials	$	13,865	$	8,923	$	22,788
Work-in-process	13,486		6,808		20,294
Finished goods	18,251		634		18,885
Supplies	—		205		205
Inventories	$	45,602	$	16,570	$	62,172

Inventories consisted of the following at December 31, 2020:

	DynaEnergetics		NobelClad		DMC Global Inc.
Raw materials	$	13,250	$	11,903	$	25,153
Work-in-process	7,062		6,682		13,744
Finished goods	12,806		669		13,475
Supplies	—		201		201
Inventories	$	33,118	$	19,455	$	52,573

4.      PURCHASED INTANGIBLE ASSETS

Our purchased intangible assets consisted of the following as of September 30, 2021:

	Gross		Accumulated Amortization		Net
Core technology	$	16,052	$	(14,223)	$	1,829
Customer relationships	36,110		(36,110)		—
Trademarks / Trade names	2,069		(2,069)		—
Total intangible assets	$	54,231	$	(52,402)	$	1,829

Our purchased intangible assets consisted of the following as of December 31, 2020:

	Gross		Accumulated Amortization		Net
Core technology	$	17,899	$	(14,234)	$	3,665
Customer relationships	37,638		(37,638)		—
Trademarks / Trade names	2,194		(2,194)		—
Total intangible assets	$	57,731	$	(54,066)	$	3,665

The change in the gross value of our purchased intangible assets from December 31, 2020 to September 30, 2021 was due to foreign currency translation and the recognition of the tax benefit of tax deductible goodwill amortization related to the 2007 acquisition of our German subsidiaries. Prior to the impairment of the goodwill related to the NobelClad and DynaEnergetics reporting units at September 30, 2017 and December 31, 2015, respectively, the tax benefit of tax amortization

14

reduced the goodwill balance. After we fully impaired the goodwill, which is only written off for U.S. GAAP purposes, the tax benefit of tax goodwill amortization reduces the gross value of the purchased intangible assets related to this acquisition.

5.      CONTRACT LIABILITIES

On occasion, we require customers to make advance payments prior to the shipment of goods in order to help finance our inventory investment on large orders or to keep customers’ credit limits at acceptable levels. Contract liabilities were as follows:

	September 30, 2021		December 31, 2020
NobelClad	$	9,450	$	4,450
DynaEnergetics	309		478
Total	$	9,759	$	4,928

We generally expect to recognize the revenue associated with contract liabilities over a time period no longer than one year, but unforeseen circumstances can cause delays in shipments associated with contract liabilities. Approximately 78% of the $4,928 recorded as contract liabilities at December 31, 2020 was recorded to net sales during the nine months ended September 30, 2021.

6.      LEASES

The Company leases real properties for use in manufacturing and as administrative and sales offices, and also leases automobiles and office equipment. The Company determines if a contract contains a lease arrangement at the inception of the contract. For leases in which the Company is the lessee, leases are classified as either finance or operating. Right of use (ROU) assets are initially measured at the present value of lease payments over the lease term plus initial direct costs, if any, with the classification affecting the pattern of expense recognition. If a lease does not provide a discount rate and the rate cannot be readily determined, an incremental borrowing rate is used to determine the future lease payments. Lease and non-lease components within the Company’s lease agreements are accounted for together.

Nearly all of the Company’s leasing arrangements are classified as operating leases. ROU asset and lease liability balances were as follows for the periods presented:

	September 30, 2021		December 31, 2020
ROU asset	$	11,198	$	10,733
Current lease liability	1,648		1,741
Long-term lease liability	10,432		10,066
Total lease liability	$	12,080	$	11,807

The ROU asset was included in “Other assets” while the current lease liability was reported in “Other current liabilities” and the long-term lease liability was reported in “Other long-term liabilities” in the Company’s Condensed Consolidated Balance Sheet. Cash paid for operating lease liabilities are recorded as cash flows from operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. For the three months ended September 30, 2021 and 2020, operating lease costs were $1,064 and $1,055, respectively. For the nine months ended September 30, 2021 and 2020, operating lease costs were $3,074 and $3,051, respectively. Operating lease costs were included in the Company’s Condensed Consolidated Statements of Operations. Short term and variable lease costs were not material for the three and nine months ended September 30, 2021 and 2020.

Certain of the Company’s leases contain renewal options and options to extend the leases for up to five years, and a majority of these options are reflected in the calculation of the ROU asset and lease liability due to the likelihood of renewal.

15

The following table summarizes the weighted average lease terms and discount rates for operating lease liabilities:

	September 30, 2021
Weighted average remaining lease term (in years)	7.71
Weighted average discount rate	5.4	%

The following table represents maturities of operating lease liabilities as of September 30, 2021:

Due within 1 year	$	1,648
Due after 1 year through 2 years	2,379
Due after 2 years through 3 years	2,160
Due after 3 years through 4 years	2,019
Due after 4 years through 5 years	1,642
Due after 5 years	5,067
Total future minimum lease payments	14,915
Less imputed interest	(2,835)
Total	$	12,080

7.      DEBT

As of September 30, 2021 we had no outstanding borrowings under our credit facility. As of December 31, 2020, outstanding borrowings consisted of the following:

Syndicated credit agreement:
Capital expenditure facility	$	11,750
Outstanding borrowings	11,750
Less: debt issuance costs	(486)
Total debt	11,264
Less: current portion of long-term debt	(3,125)
Long-term debt	$	8,139

Syndicated Credit Agreement

On March 8, 2018, we entered into a five-year $75,000 syndicated credit agreement (“credit facility”) which replaced in its entirety our prior syndicated credit facility entered into on February 23, 2015. The credit facility is with a syndicate of three banks, with KeyBank, N.A. acting as administrative agent. The facility is secured by the assets of DMC including accounts receivable, inventory, and fixed assets, as well as guarantees and share pledges by DMC and its subsidiaries. The credit facility allows for revolving loans of up to $50,000 with a $20,000 US dollar equivalent sublimit for alternative currency loans. In addition, the agreement provided for a $25,000 Capital Expenditure Facility (“Capex Facility”) which was used to assist in financing our DynaEnergetics manufacturing expansion project in Blum, Texas. At the end of year one, the Capex Facility converted to a term loan which was amortizable at 12.5% of principal per year with a balloon payment for the outstanding balance upon the credit facility maturity date in 2023. In February 2021, we repaid the remaining Capex Facility balance of $11,750.

The credit facility has a $100,000 accordion feature to increase the commitments under the revolving loan class and/or by adding a term loan subject to approval by applicable lenders.

Borrowings under the $50,000 revolving loan can be in the form of one-, two-, three-, or six-month LIBOR rate loans. Additionally, US dollar borrowings on the revolving loan can be in the form of Base Rate loans (Base Rate borrowings are based on the greater of the administrative agent’s Prime rates, an adjusted Federal Funds rate or an adjusted LIBOR rate). LIBOR loans bear interest at the applicable LIBOR rate plus an applicable margin (varying from 1.50% to 3.00%). Base Rate loans bear interest at the defined Base rate plus an applicable margin (varying from 0.50% to 2.00%).

Borrowings under the $20,000 alternate currency sublimit can be in euros, Canadian dollars, pounds sterling, and in any other currency acceptable to the administrative agent. Alternative currency borrowings denominated in euros, pounds sterling, and any other currency that is dealt with on the London Interbank Deposit Market shall be comprised of LIBOR loans and bear interest at the LIBOR rate plus an applicable margin (varying from 1.50% to 3.00%).

16

On October 22, 2020, in connection with the commencement of our at-the-market offering, we entered into an amendment to the credit facility to waive the requirement that we repay outstanding balances under the credit facility from the proceeds of any equity offering. The waiver applies to at-the-market offerings up to $75 million.

The credit facility, as amended, includes various covenants and restrictions, certain of which relate to the payment of dividends or other distributions to stockholders; redemption of capital stock; incurrence of additional indebtedness; mortgaging, pledging or disposition of major assets; and maintenance of specified ratios. As of September 30, 2021, we were in compliance with all financial covenants and other provisions of our debt agreements.

We also maintain a line of credit with a German bank for certain European operations. In July 2020, the German Bank Facility was amended to increase the borrowing capacity from €4,000 to €7,000. Of the €7,000 borrowing capacity, €4,000 was available as of September 30, 2021 after considering outstanding letters of credit.

Given that we had no outstanding debt as of September 30, 2021, our deferred debt issuance costs of $318 were reported in the “Other assets” line item in our Condensed Consolidated Balance Sheet. Our deferred debt issuance costs of $486 as of December 31, 2020 were reported in the “Long-term debt” line item in our Condensed Consolidated Balance Sheet. Deferred debt issuance costs are being amortized over the remaining term of the credit facility which expires on March 8, 2023.

8.     EQUITY OFFERINGS AND PROGRAM

Equity Offering

On May 3, 2021, the Company announced a registered public offering (“Offering”) of its stock under an automatic shelf registration statement on Form S-3ASR filed on May 3, 2021. The Company entered into an underwriting agreement with KeyBanc Capital Markets Inc. (“KeyBanc”), as representative of the underwriters (collectively, the “Underwriters”), pursuant to which the Company agreed to sell 2,500,000 shares of its $0.05 par value common stock to the Underwriters. In addition, the Underwriters were granted an option, exercisable within 30 days, to purchase up to an additional 375,000 shares of common stock to cover over-allotments, if any, on the same terms and conditions.

On May 7, 2021, DMC issued a total of 2,875,000 shares of its common stock, which included the exercise of the over-allotment option, at a market price of $45 per share resulting in gross proceeds of $129,375. Net proceeds from the offering were $123,461, after deducting underwriter fees and other expenses of $5,914. We intend to use the net proceeds from the offering for general corporate purposes, which may include acquisitions. Pending the use of the proceeds as described, we invested the proceeds of the offering in highly liquid marketable securities, including commercial paper and U.S. Treasury securities. Please see discussion of our marketable securities in Note 2.

At-the-Market Equity Program

On October 22, 2020, the Company commenced an at-the-market ("ATM") equity program under its shelf registration statement, which allows it to sell and issue up to $75 million in shares of its common stock from time to time. The Company entered into an Equity Distribution Agreement on October 22, 2020 with KeyBanc relating to the issuance and sale of shares of common stock pursuant to the program. KeyBanc is not required to sell any specific amount of securities but will act as our sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between KeyBanc and us. There is no specific date on which the ATM equity program will end and there are no minimum purchase requirements. KeyBanc is entitled to compensation for shares sold pursuant to the program in an amount up to 1.5% of the gross proceeds of any shares of common stock sold under the Equity Distribution Agreement.

During the three months ended September 30, 2021, the Company did not sell any shares of common stock through its ATM equity program. During the nine months ended September 30, 2021, the Company sold 397,820 shares of common stock through its ATM equity program for gross proceeds of $25,647 at a weighted average price per share of $64.47. Net proceeds from such sales were $25,262, after deducting commissions paid to the sales agents of approximately $385. Since the inception of the program, the Company has sold 1,006,180 shares of common stock for gross proceeds of $51,779 at a weighted average price per share of $51.46. Total net proceeds from sales through the ATM program have been $51,002. We intend to use the net proceeds from the ATM equity program for general corporate purposes, which may include working capital, debt repayment and potential acquisitions or investments in businesses, products or technologies. Pending the use of the proceeds as described, a portion of the proceeds from the ATM program has been invested in highly liquid marketable securities, including commercial paper and U.S. Treasury securities, while the balance remains in cash. Please see discussion of our marketable securities in Note 2.

17

9.     INCOME TAXES

The effective tax rate for each of the periods reported differs from the U.S. statutory rate primarily due to variation in contribution to consolidated pre-tax income from each jurisdiction for the respective periods, differences between the U.S. and foreign tax rates (which range from 20% to 34%), permanent differences between book and taxable income, and changes to valuation allowances on our deferred tax assets.

We assess the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use existing deferred tax assets. Additionally, a three-year cumulative loss at a Consolidated Financial Statement level may be viewed as negative evidence impacting a jurisdiction that by itself is not in a three-year cumulative loss position. During the nine months ended September 30, 2021 and September 30, 2020, we did not record any adjustments to previously established valuation allowances, except for adjustments related to the changes in balances of the related deferred tax assets. The Company will continue to monitor the realizability of deferred tax assets and the need for valuation allowances and will record adjustments in the periods in which facts support such adjustments.

The Tax Cuts and Jobs Act (“TCJA”) provides that foreign earnings generally can be repatriated to the U.S. without federal tax consequence. We have assessed the assertion that cumulative earnings by our foreign subsidiaries are indefinitely reinvested. We continue to permanently reinvest the earnings of our international subsidiaries and therefore we do not provide for U.S. income taxes or withholding taxes that could result from the distribution of those earnings to the U.S. parent. Nevertheless, if any such earnings were ultimately distributed to the U.S. in the form of dividends or otherwise, or if the shares of our international subsidiaries were sold or transferred, we could be subject to additional U.S. federal and state income taxes. Due to the multiple avenues in which earnings can be repatriated, and because a large portion of these earnings are not liquid, it is not practical to estimate the amount of additional taxes that might be payable on these amounts of undistributed foreign income.

During the fourth quarter of 2019, our German operating entities commenced a tax audit for fiscal years 2015 through 2017. The audit concluded in the second quarter of 2021, and we recorded additional tax expense of $25 after receiving all material assessments from the German authorities.

10.      BUSINESS SEGMENTS

Our business is organized into two segments: DynaEnergetics and NobelClad. DynaEnergetics designs, manufactures and distributes products utilized by the global oil and gas industry principally for the perforation of oil and gas wells. NobelClad is a global leader in the production of explosion-welded clad metal plates for use in the construction of corrosion resistant industrial processing equipment and specialized transition joints.

Our reportable segments are separately managed strategic business units that offer different products and services. Each segment’s products are marketed to different customer types and require different manufacturing processes and technologies.

Segment information is as follows:

 

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales
DynaEnergetics	$	44,237	$	34,201	$	124,677	$	111,065
NobelClad	22,938		21,080		63,594		60,983
Net sales	$	67,175	$	55,281	$	188,271	$	172,048

18

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Operating income
DynaEnergetics	$	1,585	$	2,171	$	6,307	$	3,886
NobelClad	3,620		2,483		8,595		5,941
Segment operating income	5,205		4,654		14,902		9,827
Unallocated corporate expenses	(2,499)		(1,594)		(6,903)		(5,851)
Stock-based compensation	(1,569)		(1,595)		(4,904)		(4,154)
Other (expense) income, net	(198)		(148)		304		(118)
Interest expense, net	(14)		(170)		(230)		(564)
Income (loss) before income taxes	$	925	$	1,147	$	3,169	$	(860)

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Depreciation and amortization
DynaEnergetics	$	2,012	$	1,866	$	6,095	$	5,410
NobelClad	967		879		2,851		2,594
Segment depreciation and amortization	2,979		2,745		8,946		8,004
Corporate and other	102		75		277		239
Consolidated depreciation and amortization	$	3,081	$	2,820	$	9,223	$	8,243

The disaggregation of revenue earned from contracts with customers based on the geographic location of the customer is as follows.

DynaEnergetics

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
United States	$	36,453	$	23,324	$	96,316	$	80,931
Canada	2,798		1,856		9,304		2,504
Egypt	671		388		2,398		2,642
Oman	665		1,148		2,117		1,842
Rest of the world	3,650		7,485		14,542		23,146
Total DynaEnergetics	$	44,237	$	34,201	$	124,677	$	111,065

19

NobelClad

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
United States	$	11,033	$	10,589	$	30,448	$	30,094
Russia	1,519		—		3,586		—
Canada	1,254		1,985		3,985		5,446
Singapore	1,009		32		1,009		857
United Arab Emirates	929		310		2,030		2,930
China	892		1,448		3,775		1,543
Italy	831		301		1,268		685
Germany	761		982		1,539		2,770
Australia	576		587		1,171		1,193
France	509		300		1,929		2,392
Netherlands	507		361		1,628		1,276
Sweden	494		541		676		1,097
Rest of the world	2,624		3,644		10,550		10,700
Total NobelClad	$	22,938	$	21,080	$	63,594	$	60,983

During the three months ended September 30, 2021, one customer in our DynaEnergetics segment accounted for approximately 11% of consolidated net sales. During the three months ended September 30, 2020, one customer in our DynaEnergetics segment accounted for approximately 11% of consolidated net sales. During the nine months ended September 30, 2021 no single customer accounted for greater than 10% of consolidated net sales. During the nine months ended September 30, 2020, one customer in our DynaEnergetics segment accounted for approximately 12% of consolidated net sales. As of September 30, 2021, one customer in our DynaEnergetics segment accounted for approximately 12% of consolidated accounts receivable. As of December 31, 2020 no single customer accounted for greater than 10% of consolidated accounts receivable.

11.      DERIVATIVE INSTRUMENTS

We are exposed to foreign currency exchange risk resulting from fluctuations in exchange rates, primarily the U.S. dollar to euro, the U.S. dollar to Canadian dollar, and, to a lesser extent, other currencies, arising from inter-company and third-party transactions entered into by our subsidiaries that are denominated in currencies other than their functional currency. Changes in exchange rates with respect to these transactions result in unrealized gains or losses if such transactions are unsettled at the end of the reporting period or realized gains or losses at settlement of the transaction. We use foreign currency forward contracts to offset foreign exchange rate fluctuations on foreign currency denominated asset and liability positions. None of these contracts are designated as accounting hedges, and all changes in the fair value of the forward contracts are recognized in “Other (expense) income, net” within our Condensed Consolidated Statements of Operations.

We execute derivatives with a specialized foreign exchange brokerage firm as well as other large financial institutions. The primary credit risk inherent in derivative agreements is the possibility that a loss may occur from the nonperformance of a counterparty to the agreements. We perform a review of the credit risk of our counterparties at the inception of the contract and on an ongoing basis. We anticipate that our counterparties will be able to fully satisfy their obligations under the agreements but will take action if doubt arises regarding the counterparties’ ability to perform.

As of September 30, 2021 and December 31, 2020, the notional amounts of the forward currency contracts the Company held were $11,746 and $2,092, respectively. At September 30, 2021 and December 31, 2020, the fair values of outstanding foreign currency forward contracts were $0.

The following table presents the location and amount of net losses from hedging activities:

		Three months ended September 30,				Nine months ended September 30,
Derivative	Statements of Operations Location	2021		2020		2021		2020
Foreign currency contracts	Other (expense) income, net	$	(253)	$	(1,045)	$	(187)	$	(917)

20

12.    COMMITMENTS AND CONTINGENCIES

Contingent Liabilities

The Company records an accrual for contingent liabilities when a loss is both probable and reasonably estimable. If some amount within a range of loss appears to be a better estimate than any other amount within the range, that amount is accrued. When no amount within a range of loss appears to be a better estimate than any other amount, the lowest amount in the range is accrued.

Legal Proceedings

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

13.     RESTRUCTURING EXPENSES AND ASSET IMPAIRMENTS

During the first quarter of 2021, NobelClad recorded an accrual for additional severance liabilities of $116 which were agreed to with local labor authorities for employees terminated as part of closing manufacturing operations in France in 2018.

During the third quarter of 2020, DynaEnergetics sold its Tyumen, Siberia production facility to a third-party for $448, which was equal to the carrying value of the assets held for sale.

During the second quarter of 2020 the COVID-19 pandemic-related collapse in oil and gas demand led to a downturn in well completions and the corresponding demand for DynaEnergetics’ products. As a result, DynaEnergetics recorded asset impairment charges of $1,181 on certain manufacturing assets that will no longer be utilized in production at its Blum, Texas and Troisdorf, Germany facilities. Additionally, both DynaEnergetics and NobelClad further reduced the respective workforces during the quarter. Finally, DynaEnergetics continued activities to prepare its Tyumen, Siberia facility for sale.

During the first quarter of 2020, DMC reduced its workforce by 264 positions to address a sharp decline in well completions in the Company’s core oil and gas end market principally due to the COVID-19 pandemic. The workforce reduction impacted full-time, part-time and temporary direct-labor roles in manufacturing and assembly at DynaEnergetics as well as general and administrative positions at DynaEnergetics, NobelClad, and at DMC’s corporate office.

Total restructuring and impairment charges incurred for these programs are as follows and are reported in the “Restructuring expenses and asset impairments” line item in our Condensed Consolidated Statements of Operations:

	Nine months ended September 30, 2021
	Severance		Other Exit Costs		Total
NobelClad	$	116	$	11	$	127
Total	$	116	$	11	$	127

	Three months ended September 30, 2020
	Severance		Contract Termination Costs		Other Exit Costs		Total
DynaEnergetics	$	109	$	8	$	16	$	133
NobelClad	—		—		10		10
Total	$	109	$	8	$	26	$	143

21

	Nine months ended September 30, 2020
	Severance		Asset Impairment		Contract Termination Costs		Equipment Moving Costs		Other Exit Costs		Total
DynaEnergetics	$	936	$	1,181	$	19	$	126	$	660	$	2,922
NobelClad	244		—		—		—		20		264
Corporate	119		—		—		—		—		119
Total	$	1,299	$	1,181	$	19	$	126	$	680	$	3,305

During the nine months ended September 30, 2021, the changes to the restructuring liability associated with these programs is summarized below:

	December 31, 2020		Net expense		Payments and Other Adjustments		Currency Adjustments		September 30, 2021
Severance	$	958	$	116	$	(56)	$	(57)	$	961
Other exit costs	—		11		(11)		—		—
Total	$	958	$	127	$	(67)	$	(57)	$	961

22

ITEM 2.      Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our historical consolidated financial statements and notes, as well as the selected historical consolidated financial data that is included in our Annual Report filed on Form 10-K for the year ended December 31, 2020.

Unless stated otherwise, all currency amounts are presented in thousands of U.S. dollars (000s).

Overview

General

DMC Global Inc. (“DMC”) operates two technical product and process business segments serving the energy, industrial and infrastructure markets. These segments, DynaEnergetics and NobelClad, operate globally through an international network of manufacturing, distribution and sales facilities.

 Our diversified segments each provide a suite of unique technical products to niche sectors of the global energy, industrial and infrastructure markets, and each has established a strong or leading position in the markets in which it participates. With an underlying focus on generating free cash flow, our objective is to sustain and grow the market share of our businesses through increased market penetration, development of new applications, and research and development of new and adjacent products that can be sold across our global network of sales and distribution facilities. We routinely explore acquisitions of related businesses that could strengthen or add to our existing product portfolios, or expand our geographic footprint and market presence. We also seek acquisition opportunities outside our current markets that would complement our existing businesses and enable us to build a stronger and more diverse company.

DynaEnergetics

DynaEnergetics designs, manufactures and distributes products utilized by the global oil and gas industry principally for the perforation of oil and gas wells. These products are sold to oilfield service companies in the U.S., Europe, Canada, Africa, the Middle East, and Asia. DynaEnergetics also sells directly to end-users. The market for perforating products, which are used during the well completion process, generally corresponds with oil and gas exploration and production activity. Exploration activity over the last several years has led to increasingly complex well completion operations, which in turn has increased the demand for high quality and technically advanced perforating products.

Cost of products sold for DynaEnergetics includes the cost of metals, explosives and other raw materials used to manufacture shaped charges, detonating products and perforating guns as well as employee compensation and benefits, freight in, depreciation of manufacturing facilities and equipment, manufacturing supplies and other manufacturing overhead expenses.

NobelClad

NobelClad produces explosion-welded clad metal plates for use in the construction of corrosion resistant industrial processing equipment and specialized transition joints. While a significant portion of the demand for our clad metal products is driven by maintenance and retrofit projects at existing chemical processing, petrochemical processing, oil refining, and aluminum smelting facilities, new plant construction and large plant expansion projects also account for a significant portion of total demand. These industries tend to be cyclical in nature and timing of new order inflow remains difficult to predict. We use backlog as a primary means to measure the immediate outlook for our NobelClad business. We define “backlog” at any given point in time as all firm, unfulfilled purchase orders and commitments at that time. Most firm purchase orders and commitments are realized, and we expect to fill most backlog orders within the following 12 months. NobelClad’s backlog increased to $42,867 at September 30, 2021 from $39,884 at December 31, 2020.

Cost of products sold for NobelClad includes the cost of metals and alloys used to manufacture clad metal plates, the cost of explosives, employee compensation and benefits, freight in, outside processing costs, depreciation of manufacturing facilities and equipment, manufacturing supplies and other manufacturing overhead expenses.

In the first quarter of 2021, under provisions of legislation enacted in December 2020 the Company became eligible for the Employee Retention Credit (“ERC”) under the Coronavirus Aid, Relief, and Economic Security Act, as amended (“CARES Act”). As a result of the new legislation, the Company was able to claim a refundable tax credit equal to 70% of the qualified wages they paid to employees during the first and second quarters of 2021, limited to $10 per employee per quarter. Thus, the maximum ERC amount available to the Company was $7 per employee during the first three quarters of 2021.

23

Factors Affecting Results

•Consolidated sales of $67,175 increased 3% versus the second quarter of 2021 and 22% versus the third quarter of 2020. DynaEnergetics reported a 19% sequential increase in unit sales of its fully integrated and factory-assembled DS perforating systems in North America. The increase was partially offset by supply chain bottlenecks that impacted certain international orders at both DynaEnergetics and NobelClad. The year-over-year increase in consolidated sales primarily was due to a recovery in energy demand, North American drilling and well completions activity and sales at DynaEnergetics, which has been severely impacted by the COVID-19 pandemic.

•DynaEnergetics sales of $44,237 in the third quarter of 2021 increased 5% compared with the second quarter of 2021 due to a recovery in energy demand and prices, which led to higher North American drilling and well completions, and increased sales of DynaEnergetics’ DS perforating systems. The increase in North America was offset by a slowdown in international sales volume driven by supply chain disruptions and travel restrictions. Sales increased 29% compared with the third quarter of 2020, which was severely impacted by the COVID-19 pandemic.

•NobelClad’s sales of $22,938 in the third quarter of 2021 decreased 1% compared to the second quarter of 2021 primarily due to shipping and supply chain bottlenecks and increased 9% compared with the third quarter of 2020 reflecting increased shipments of projects out of backlog.

•Consolidated gross profit was 25% in the third quarter of 2021 versus 26% in the second quarter of 2021 and 25% in the third quarter of 2020. Gross profit was flat versus last year as the third quarter of 2021 and reflects receipt of $1,800 ERC under the CARES Act, while the third quarter of 2020 benefited from higher-margin international sales at DynaEnergetics that were $4.6 million greater than this year’s third quarter.

•Consolidated selling, general and administrative expenses were $15,314 in the third quarter of 2021 compared with $11,616 in the third quarter of 2020. The increase primarily was due to higher litigation expenses related to patent enforcement actions against companies that we believe infringe on DynaEnergetics’ patents, restoration of variable compensation, and resumption of business-related travel. These increases were partially offset by receipt of $769 ERC under the CARES Act.

•Restructuring expenses and asset impairments of $143 in the third quarter of 2020 primarily related to costs associated with the sale of the Tyumen, Siberia manufacturing facility.

•Cash and marketable securities of $181,952 increased $128,029 from $53,923 at December 31, 2020. The increase primarily relates to proceeds from our registered public equity offering in May 2021 and under our at-the-market equity offering program (“ATM equity program”).

Outlook

Supply chain disruptions and travel restrictions challenged the international operations of both DMC businesses during the third quarter of 2021. As a result, consolidated sales were below our expectations. DynaEnergetics’ international sales were down $2.8 million sequentially versus the $7.4 million reported in second quarter; and at NobelClad, disruptions in global metals supplies slowed activity at its U.S. and European manufacturing facilities.

We remain in a period of rising material and labor costs at both DynaEnergetics and NobelClad; both of which could also be impacted by supply-chain disruptions and availability of direct labor. NobelClad was awarded an $8,800 order during the second quarter of 2021 for titanium clad plates that will be used to fabricate specialized equipment for a large purified terephthalic acid (PTA) plant. The plant was engineered in Europe, will be built in Southwest Asia and will include titanium-clad equipment fabricated in China. The clad plates, which will be used to fabricate pressure vessels and heat exchangers, are being manufactured at NobelClad’s production facility in Mt. Braddock, Pennsylvania. This large order should help offset the pandemic-related downturn in NobelClad’s base repair and maintenance business. However, receipt of the raw materials required to produce the order has been delayed due to supply chain bottlenecks, and while NobelClad still expects to receive the materials and fulfil the order during the fourth quarter, there remains a risk that some, or all, of the shipment will occur after year end.

In North America, rising crude prices led to higher well completion activity in the third quarter of 2021, which drove a strong increase in unit sales of DynaEnergetics’ fully integrated and factory-assembled DS perforating systems. However, pricing for products and services remained weak. Additionally, rising material and labor costs combined with availability of

24

direct labor are negatively impacting the recovery in DynaEnergetics. As market conditions continue to improve and operators implement their 2022 budgets, we believe pricing will begin to improve as well. We expect DynaEnergetics will be among the first to benefit from strengthening prices, as it offers a highly differentiated product line. Factory-assembled DS systems are delivered just in time to the wellsite, eliminating assembly operations and requiring fewer people on location.

In the fourth quarter of 2021, DynaEnergetics announced a 5% price increase that will go into effect November 22, 2021. The increase was implemented to offset higher labor and material costs, as well as the anticipated wind down of the CARES Act. DynaEnergetics expects to implement additional increases during 2022 as it seeks to return margins to levels that reflect the inherent value of its products.

We believe many of the pre-wired carriers in the market incorporate features that violate DynaEnergetics patents, and we are taking aggressive legal action against the companies that make these products. DynaEnergetics has made significant investments in technologies and products that have improved the safety, efficiency and performance of its customers’ well completions, and have enhanced the effectiveness and profitability of the industry as a whole. Our patent strategy is designed to protect these investments and provide transparency so others can innovate without violating our intellectual property. These lawsuits have increased our general and administrative expenses in the first nine months of 2021, and we expect these costs to be ongoing throughout the remainder of 2021 and into 2022.

In the third quarter of 2021, NobelClad introduced DetaPipe™, a high-performance clad-pipe solution for the chemical and metal-processing markets. This product offering is expected to provide customers with a better-performing, cost-effective alternative to solid zirconium or titanium pipe in their high-pressure, high temperature processing environments.

In March 2021, provisions of legislation modified and extended the ERC under the CARES Act through December 31, 2021 for eligible companies. Under this extension, we were able to claim the refundable tax credit for the quarter ended September 30, 2021, but at this time there is no guarantee that we will be able to claim the credit for the quarter ended December 31, 2021. This could negatively impact our gross profit margin and operating income in the fourth quarter of 2021.

From time to time, we also may continue to use our ATM equity program, which commenced in October 2020, to raise additional capital efficiently and responsibly. We did not sell shares under our ATM equity program during the second or third quarters of 2021. During the first quarter of 2021, we sold 397,820 shares of common stock at a weighted average price per share of $64.47 through our ATM equity program and received net proceeds of $25,262. In addition to sales under our ATM equity program, during the second quarter of 2021 we issued a total of 2,875,000 shares of our common stock through a registered public offering at a market price of $45 per share and received net proceeds of $123,461.

Use of Non-GAAP Financial Measures

Adjusted EBITDA is a non-GAAP (generally accepted accounting principles) measure that we believe provides an important indicator of our ongoing operating performance and that we use in operational and financial decision-making. We define EBITDA as net income or loss plus or minus net interest, taxes, depreciation and amortization. Adjusted EBITDA excludes from EBITDA stock-based compensation, restructuring and impairment charges and, when appropriate, other items that management does not utilize in assessing DMC’s operating performance (as further described in the tables below). As a result, internal management reports used during monthly operating reviews feature Adjusted EBITDA and certain management incentive awards are based, in part, on the amount of Adjusted EBITDA achieved during the year.

Adjusted operating income (loss) is defined as operating income (loss) plus restructuring and impairment charges and, when appropriate, other items that management does not utilize in assessing DMC’s operating performance.

Adjusted net income (loss) is defined as net income (loss) plus restructuring and impairment charges and, when appropriate, other items that management does not utilize in assessing DMC’s operating performance. Adjusted diluted earnings per share is defined as diluted earnings per share plus restructuring and impairment charges and, when appropriate, other items that management does not utilize in assessing DMC’s operating performance.

Adjusted operating income (loss), adjusted net income (loss), and adjusted diluted earnings per share are presented because management believes these measures are useful to understand the effects of restructuring and impairment charges on DMC’s operating income (loss), net income (loss) and diluted earnings per share, respectively.

Net cash is a non-GAAP measure we use to supplement information in our Consolidated Financial Statements. We define net cash as total cash, cash equivalents and marketable securities less total debt. In addition to conventional measures

25

prepared in accordance with GAAP, the Company uses this information to evaluate its performance, and we believe that certain investors may do the same.

The presence of non-GAAP financial measures in this report is not intended to suggest that such measures be considered in isolation or as a substitute for, or as superior to, DMC’s GAAP information, and investors are cautioned that the non-GAAP financial measures are limited in their usefulness. Because not all companies use identical calculations, DMC’s presentation of non-GAAP financial measures may not be comparable to similarly titled measures of other companies.

26

Consolidated Results of Operations

Three months ended September 30, 2021 compared with three months ended September 30, 2020

	Three months ended September 30,
	2021			2020			$ change		% change
Net sales	$	67,175		55,281			$	11,894	22	%
Gross profit	16,662			13,593			3,069		23	%
Gross profit percentage	24.8		%	24.6		%
COSTS AND EXPENSES:
General and administrative expenses	9,721			6,911			2,810		41	%
% of net sales	14.5		%	12.5		%
Selling and distribution expenses	5,593			4,705			888		19	%
% of net sales	8.3		%	8.5		%
Amortization of purchased intangible assets	211			369			(158)		(43	%)
% of net sales	0.3		%	0.7		%
Restructuring expenses and asset impairments	—			143			(143)		(100	%)
Operating income	1,137			1,465			(328)		(22	%)
Other expense, net	(198)			(148)			(50)		(34	%)
Interest expense, net	(14)			(170)			156		92	%
Income before income taxes	925			1,147			(222)		(19	%)
Income tax provision	522			139			383		276	%
Net income	403			1,008			(605)		(60	%)
Adjusted EBITDA	$	5,787		$	6,023		$	(236)	(4	%)

Net sales increased $11,894 compared with the third quarter of 2020. The increase primarily was due to the recovery in energy demand and prices, which led to increased drilling and well completion activity in North America and increased sales of DynaEnergetics’ DS perforating systems. The third quarter of 2020 was negatively impacted by the drop in demand for oil and gas drilling and completion activity and low energy prices due to the COVID-19 pandemic.

Gross profit percentage increased to 24.8% compared with the third quarter of 2020 primarily due to the impact of higher volume on fixed manufacturing overhead expenses and improved project mix at NobelClad. Additionally, gross profit percentage was also favorably impacted by receipt of $1,800 ERC under the CARES Act. These favorable items were offset by a decline in high-margin international sales and higher material costs at DynaEnergetics.

General and administrative expenses increased $2,810 compared with the third quarter of 2020 primarily due to an increase in outside services costs by $2,251, which was primarily related to patent infringement litigation in which DynaEnergetics is the plaintiff, an increase from resumption of business-related travel by $344, an increase from the restoration of variable compensation by $326, and salaries by $158 due to headcount additions and merit increases. These increases were partially offset by receipt of $349 ERC under the CARES Act.

Selling and distribution expenses increased $888 compared with the third quarter of 2020 primarily due to increases in salaries by $548 due to headcount additions and merit increases, depreciation expense by $354, increases from the resumption of business-related travel by $168, higher outside service costs by $176, and increases from the restoration of variable compensation by $156. These increases were partially offset by receipt of $420 ERC under the CARES Act.

Restructuring expenses and asset impairments in the third quarter of 2020 primarily related to costs associated with the sale of the Tyumen, Siberia manufacturing facility.

Operating income of $1,137 in the third quarter of 2021 decreased compared to the same period last year primarily due to a decrease in earnings at DynaEnergetics partially offset by higher earnings at NobelClad. Operating income was also favorably impacted by receipt of $2,569 ERC under the CARES Act in the third quarter of 2021.

27

Other expense, net of $198 in the third quarter of 2021 primarily related to net unrealized and realized foreign currency exchange losses. Currency gains and losses can arise when subsidiaries enter into inter-company and third-party transactions that are denominated in currencies other than their functional currency, including foreign currency forward contracts used to offset foreign exchange rate fluctuations on certain foreign currency denominated asset and liability positions.

Interest expense, net of $14 decreased compared with the third quarter of 2020 primarily due to the repayment in full of our outstanding debt in the first quarter of 2021. Interest expense, net was also favorably impacted by interest on our investments in marketable securities.

Income tax provision of $522 was recorded on income before income taxes of $925. Our most significant operations are in the United States, which has a 21% statutory income tax rate, and Germany, which has a 33% statutory income tax rate. The mix of income or loss before income taxes between these jurisdictions is one of the primary drivers of the difference between our 21% statutory tax rate and our effective tax rate. The rate was also impacted unfavorably by geographic mix of pretax income, state taxes, and certain compensation expenses that are not tax deductible in the U.S. We recorded an income tax benefit of $139 on income before income taxes of $1,147 for the third quarter of 2020. The effective rate was impacted unfavorably by geographic mix of pretax income, state taxes, and certain compensation expenses that are not tax deductible in the U.S. The effective rate was also impacted favorably by discrete items of $247.

Net income for the three months ended September 30, 2021 was $403, or $0.02 per diluted share, compared to net income of $1,008, or $0.07 per diluted share, for the same period in 2020.

Adjusted EBITDA decreased compared with the third quarter of 2020 primarily due to the factors discussed above. See “Overview” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.

	Three months ended September 30,
	2021		2020
Net income	$	403	$	1,008
Interest expense, net	14		170
Income tax provision	522		139
Depreciation	2,870		2,451
Amortization of purchased intangible assets	211		369
EBITDA	4,020		4,137
Restructuring expenses and asset impairments	—		143
Stock-based compensation	1,569		1,595
Other expense, net	198		148
Adjusted EBITDA	$	5,787	$	6,023

Adjusted Net Income and Adjusted Diluted Earnings per Share decreased compared with the third quarter of 2020 due to the factors discussed above. See "Overview" above for the explanation of the use of non-GAAP measures. The following is a reconciliation of the most directly comparable GAAP measures to Adjusted Net Income and Adjusted Diluted Earnings Per Share.

	Three months ended September 30, 2021
	Pre-Tax		Tax (Benefit)		Net		Diluted weighted average shares outstanding	Diluted EPS
Net income, as reported	$	925	$	522	$	403	18,739,085	$	0.02
Adjusted net income	$	925	$	522	$	403	18,739,085	$	0.02

28

	Three months ended September 30, 2020
	Pre-Tax		Tax (Benefit) Provision		Net		Diluted weighted average shares outstanding	Diluted EPS
Net income, as reported	$	1,147	$	139	$	1,008	14,820,881	$	0.07
Restructuring expenses and asset impairments:
DynaEnergetics	133		(39)		172		14,820,881	0.01
NobelClad	10		3		7		14,820,881	—
Adjusted net income	$	1,290	$	103	$	1,187	14,820,881	$	0.08

Nine months ended September 30, 2021 compared with nine months ended September 30, 2020

	Nine months ended September 30,
	2021			2020			$ change		% change
Net sales	$	188,271		$	172,048		$	16,223	9	%
Gross profit	46,546			44,667			1,879		4	%
Gross profit percentage	24.7		%	26.0		%
COSTS AND EXPENSES:
General and administrative expenses	26,121			21,744			4,377		20	%
% of net sales	13.9		%	12.6		%
Selling and distribution expenses	16,380			18,720			(2,340)		(13	%)
% of net sales	8.7		%	10.9		%
Amortization of purchased intangible assets	823			1,076			(253)		(24	%)
% of net sales	0.4		%	0.6		%
Restructuring expenses	127			3,305			(3,178)		(96	%)
Operating income (loss)	3,095			(178)			3,273		1,839	%
Other income (expense), net	304			(118)			422		358	%
Interest expense, net	(230)			(564)			334		59	%
Income (loss) before income taxes	3,169			(860)			4,029		468	%
Income tax provision (benefit)	610			(375)			985		263	%
Net income (loss)	2,559			(485)			3,044		628	%
Adjusted EBITDA	$	17,349		$	15,524		$	1,825	12	%

Net sales increased $16,223 compared with the same period of 2020 primarily due to the recovery in energy demand, which led to higher energy prices, increased drilling and well completion activity in North America and increased sales of DynaEnergetics’ DS perforating systems. The first nine months of 2020 was severely impacted by the drop in demand for oil and gas and related drilling and well completion activity due to the COVID-19 pandemic.

Gross profit percentage decreased to 24.7% compared with the nine months of 2020 primarily due to lower average selling prices and a decrease in international sales at DynaEnergetics. The decline was partially offset by excess capacity charges and inventory reserves that were recorded at DynaEnergetics in the second quarter of 2020, as well as favorable project mix in NobelClad, and receipt of $4,134 ERC under the CARES Act in the first nine months of 2021.

General and administrative expenses increased $4,377 compared with the nine months of 2020 primarily due to an increase in outside services costs by $3,721 mostly related to patent infringement litigation in which DynaEnergetics is the plaintiff, restoration of variable compensation by $1,050, and an increase in stock-based compensation expense by $890. The increases were partially offset by receipt of $1,028 ERC under the CARES Act.

29

Selling and distribution expenses decreased $2,340 compared with the same period of 2020 primarily due to reductions in provisions for expected credit losses by $3,227 and receipt of $1,236 ERC under the CARES Act. The decreases were partially offset by increases in depreciation expense by $900, salaries by $517 due to headcount additions and merit increases, increases from the restoration of variable compensation by $479, and higher outside service costs by $271.

Restructuring expenses and asset impairments of $127 in the nine months of 2021 primarily related to additional severance accruals for employee terminations associated with closing manufacturing operations in France in 2018. Expenses in 2020 primarily related to downsizing our direct labor workforce at DynaEnergetics in response to declining crude oil prices and corresponding demand for well perforating systems due to the COVID-19 pandemic.

Operating income of $3,095 in 2021 reflect higher earnings at DynaEnergetics and NobelClad during 2021, including receipt of $6,398 ERC under the CARES Act in the first nine months of 2021.

Other income, net of $304 in the nine months of 2021 primarily related to a gain on the sale of a fully depreciated fixed asset by DynaEnergetics partially offset with net unrealized and realized foreign currency exchange losses. Currency gains and losses can arise when subsidiaries enter into inter-company and third-party transactions that are denominated in currencies other than their functional currency, including foreign currency forward contracts used to offset foreign exchange rate fluctuations on certain foreign currency denominated asset and liability positions.

Interest expense, net of $230 decreased compared with the nine months of 2020 primarily due to the repayment in full of our outstanding debt in the first quarter of 2021. Interest expense, net was also favorably impacted by interest on our investments in marketable securities.

Income tax provision of $610 was recorded on income before income taxes of $3,169. Our most significant operations are in the United States, which has a 21% statutory income tax rate, and Germany, which has a 33% statutory income tax rate. The mix of income or loss before income taxes between these jurisdictions is one of the main drivers of the difference between our 21% statutory tax rate and our effective tax rate. The effective income tax rate was impacted favorably by discrete stock-based compensation windfall benefits of $832. The rate was also impacted unfavorably by geographic mix of pretax income, state taxes, and certain compensation expenses that are not tax deductible in the U.S. We recorded an income tax benefit of $375 on loss before income taxes of $860 for the nine months of 2020. The effective rate was impacted unfavorably by geographic mix of pretax income, state taxes, and certain compensation expenses that are not tax deductible in the U.S. The effective rate was also impacted favorably by discrete items of $549.

Net income for the nine months ended September 30, 2021 was $2,559, or $0.15 per diluted share, compared to net loss of $485, or $0.03 per diluted share, for the same period in 2020.

Adjusted EBITDA increased compared with the first nine months of 2020 primarily due to the factors discussed above. See “Overview” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.

	Nine months ended September 30,
	2021		2020
Net income (loss)	$	2,559	$	(485)
Interest expense, net	230		564
Income tax provision (benefit))	610		(375)
Depreciation	8,400		7,167
Amortization of purchased intangible assets	823		1,076
EBITDA	12,622		7,947
Restructuring expenses and asset impairments	127		3,305
Stock-based compensation	4,904		4,154
Other (income) expense, net	(304)		118
Adjusted EBITDA	$	17,349	$	15,524

Adjusted Net Income and Adjusted Diluted Earnings per Share increased compared with the first nine months of 2020 due to the factors discussed above. See "Overview" above for the explanation of the use of non-GAAP measures. The following is a reconciliation of the most directly comparable GAAP measures to Adjusted Net Income and Adjusted Diluted Earnings Per Share.

30

	Nine months ended September 30, 2021
	Pre-Tax		Tax Provision		Net		Diluted weighted average shares outstanding	Diluted EPS
Net income, as reported	$	3,169	$	610	$	2,559	17,250,525	$	0.15
Restructuring expenses and asset impairments:
NobelClad	127		—		127		17,250,525	0.01
Adjusted net income	3,296		610		2,686		17,250,525	0.16

	Nine months ended September 30, 2020
	Pre-Tax		Tax (Benefit) Provision		Net		Diluted weighted average shares outstanding	Diluted EPS
Net loss, as reported	$	(860)	$	(375)	$	(485)	14,759,062	$	(0.03)
Restructuring expenses and asset impairments:
DynaEnergetics	2,922		896		2,026		14,759,062	0.14
NobelClad	264		77		187		14,759,062	0.01
Corporate	119		25		94		14,759,062	0.01
Adjusted net income	$	2,445	$	623	$	1,822	14,759,062	$	0.13

Business Segment Financial Information

We primarily evaluate performance and allocate resources based on segment revenues, operating income and adjusted EBITDA as well as projected future performance. Segment operating income is defined as revenues less expenses identifiable to the segment. Segment operating income will reconcile to consolidated income before income taxes by deducting unallocated corporate expenses, including stock-based compensation, net other expense, and net interest expense.

DynaEnergetics

Three months ended September 30, 2021 compared with three months ended September 30, 2020

	Three months ended September 30,
	2021			2020			$ change		% change
Net sales	$	44,237		$	34,201		$	10,036	29	%
Gross profit	9,924			8,194			1,730		21	%
Gross profit percentage	22.4		%	24.0		%
COSTS AND EXPENSES:
General and administrative expenses	4,990			3,176			1,814		57	%
Selling and distribution expenses	3,260			2,445			815		33	%
Amortization of purchased intangible assets	89			269			(180)		(67	%)
Restructuring expenses and asset impairments	—			133			(133)		(100	%)
Operating income	1,585			2,171			(586)		(27	%)
Adjusted EBITDA	$	3,597		$	4,170		$	(573)	(14	%)

Net sales were $10,036 higher than the third quarter of 2020 due to a recovery in energy demand, which led to increased drilling and well completion activity in North America and increased sales of DynaEnergetics’ DS perforating systems. The year-over-year increase in net sales from North American activity was partially offset by lower international sales.

31

Gross profit percentage decreased to 22.4% compared with the third quarter of 2020 primarily due to a decline in high-margin international sales and higher material costs. These items were partially offset by receipt of $1,250 ERC under the CARES Act in the third quarter of 2021.

General and administrative expenses increased $1,814 compared with the third quarter of 2020 primarily due to an increase in outside services costs by $1,969 mostly related to patent infringement litigation in which DynaEnergetics is the plaintiff. The increase was partially offset by receipt of $100 ERC under the CARES Act.

Selling and distribution expenses increased $815 compared with the third quarter of 2020 primarily due to increases in salaries, benefits, other-payroll related costs by $359 due to headcount additions and merit increases, increases in depreciation expense by $335, higher outside service costs by $170, increases from the restoration of variable compensation by $120, and an increase from resumption of business-related travel by $96. The increases were partially offset by receipt of $279 ERC under the CARES Act.

Restructuring expenses and asset impairments in 2020 primarily related to costs associated with the sale of the Tyumen, Siberia manufacturing facility.

Operating income decreased $586 compared with the third quarter of 2020 primarily due to the impact of lower high margin international sales, higher material costs, and higher selling, general and administrative expenses. The decline was partially offset by receipt of $1,629 ERC under the CARES Act.

Adjusted EBITDA decreased compared with the third quarter of 2020 due to the factors discussed above. See “Overview” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.

	Three months ended September 30,
	2021		2020
Operating income	$	1,585	$	2,171
Adjustments:
Restructuring expenses and asset impairments	—		133
Adjusted operating income	1,585		2,304
Depreciation	1,923		1,597
Amortization of purchased intangibles	89		269
Adjusted EBITDA	$	3,597	$	4,170

Nine months ended September 30, 2021 compared with nine months ended September 30, 2020

	Nine months ended September 30,
	2021			2020			$ change		% change
Net sales	$	124,677		$	111,065		$	13,612	12	%
Gross profit	29,034			29,640			(606)		(2)	%
Gross profit percentage	23.3		%	26.7		%
COSTS AND EXPENSES:
General and administrative expenses	12,574			10,164			2,410		24	%
Selling and distribution expenses	9,702			11,880			(2,178)		(18)	%
Amortization of purchased intangible assets	451			788			(337)		(43)	%
Restructuring expenses and asset impairments	—			2,922			(2,922)		(100)	%
Operating income	6,307			3,886			2,421		62	%
Adjusted EBITDA	$	12,402		$	12,218		$	184	2	%

Net sales were $13,612 higher than in the same period of 2020 due to a recovery in energy demand, which led to increased energy prices, drilling and well completion activity in North America, and increased sales of DynaEnergetics’ DS perforating systems. The year-over-year increase in net sales was partially offset by lower international sales. The first nine months of 2020 was severely impacted by the drop in energy demand and related drilling and completion activity due to the COVID-19 pandemic.

32

Gross profit percentage decreased to 23.3% compared with 2020 primarily due to lower average selling prices in 2021, which also contributed to lower fixed cost absorption, as well as a decline in high-margin international sales. The decline was partially offset by receipt of $2,696 ERC under the CARES Act.

General and administrative expenses increased $2,410 compared with 2020 primarily due to an increase in outside services costs by $3,525 mostly related to patent infringement litigation in which DynaEnergetics is the plaintiff. The increase was partially offset by receipt of $333 ERC under the CARES Act.

Selling and distribution expenses decreased $2,178 compared with 2020 primarily due to reductions in provisions for expected credit losses by $2,915 and receipt of $800 ERC under the CARES Act. These decreases were partially offset by increases in depreciation expense by $901, increases in salaries by $491 due to headcount additions and merit increases, and increases from the restoration of variable compensation by $411.

Restructuring expenses and asset impairments in 2020 primarily related to downsizing our direct labor workforce in response to declining crude oil prices and corresponding demand for well perforating systems. We also recorded asset impairments and incurred costs associated with the sale of the Tyumen, Siberia manufacturing facility.

Operating income increased $2,421 compared with 2020 as increased sales volume, receipt of $3,829 ERC under the CARES Act, and a reduction in the provisions for expected credit losses more than offset lower average selling prices.

Adjusted EBITDA increased compared with 2020 due to the factors discussed above. See “Overview” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.

	Nine months ended September 30,
	2021		2020
Operating income	$	6,307	$	3,886
Adjustments:
Restructuring expenses and asset impairments	—		2,922
Adjusted operating income	6,307		6,808
Depreciation	5,644		4,622
Amortization of purchased intangibles	451		788
Adjusted EBITDA	$	12,402	$	12,218

NobelClad

Three months ended September 30, 2021 compared with three months ended September 30, 2020

	Three months ended September 30,
	2021			2020			$ change		% change
Net sales	$	22,938		$	21,080		$	1,858	9	%
Gross profit	6,883			5,577			1,306		23	%
Gross profit percentage	30.0		%	26.5		%
COSTS AND EXPENSES:
General and administrative expenses	933			878			55		6	%
Selling and distribution expenses	2,208			2,106			102		5	%
Amortization of purchased intangible assets	122			100			22		22	%
Restructuring expenses and asset impairments	—			10			(10)		(100	%)
Operating income	3,620			2,483			1,137		46	%
Adjusted EBITDA	$	4,587		$	3,372		$	1,215	36	%

Net sales increased $1,858 compared with the third quarter of 2020 primarily due to the timing of shipment of projects out of backlog.

33

Gross profit percentage of 30.0% increased compared with the third quarter of 2020 primarily due to better project mix, higher sales volume on fixed overhead expenses and receipt of $550 ERC under the CARES Act.

General and administrative expenses increased $55 compared with the third quarter of 2020 primarily due to increases from the resumption of business travel by $36 and the restoration of variable compensation by $11.

Selling and distribution expenses increased $102 compared with the third quarter of 2020 primarily due to increases from the resumption of business travel by $72 and the restoration of variable compensation by $36.

Restructuring expenses and asset impairments of $10 in 2020 related to severance costs associated with the past closure of a manufacturing facility in France.

Operating income increased $1,137 compared with the third quarter of 2020 primarily due to improved project mix, the favorable impact of higher sales volume on fixed overhead expenses, and receipt of $719 ERC under the CARES Act. The increase was partially offset by higher general and administrative and selling and distribution expenses.

Adjusted EBITDA increased compared with the third quarter of 2020 primarily due to the factors discussed above. See “Overview” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.

	Three months ended September 30,
	2021		2020
Operating income	$	3,620	$	2,483
Adjustments:
Restructuring expenses and asset impairments	—		10
Adjusted operating income	3,620		2,493
Depreciation	845		779
Amortization of purchased intangibles	122		100
Adjusted EBITDA	$	4,587	$	3,372

Nine months ended September 30, 2021 compared with nine months ended September 30, 2020

	Nine months ended September 30,
	2021			2020			$ change		% change
Net sales	$	63,594		$	60,983		$	2,611	4	%
Gross profit	17,960			15,530			2,430		16	%
Gross profit percentage	28.2		%	25.5		%
COSTS AND EXPENSES:
General and administrative expenses	2,636			2,649			(13)		—	%
Selling and distribution expenses	6,230			6,388			(158)		(2)	%
Amortization of purchased intangible assets	372			288			84		29	%
Restructuring expenses and asset impairments	127			264			(137)		(52)	%
Operating income	8,595			5,941			2,654		45	%
Adjusted EBITDA	$	11,573		$	8,799		$	2,774	32	%

Net sales were $2,611 higher compared with 2020 primarily due to the timing of shipment of projects out of backlog.

Gross profit percentage of 28.2% increased compared with of 2020 primarily due to improved project mix, the favorable impact of higher sales volume on fixed expenses, and receipt of $1,438 ERC under the CARES Act.

General and administrative expenses were essentially flat compared with 2020.

Selling and distribution expenses decreased $158 compared with of 2020 primarily due to a prior year provision for expected credit losses of $178 associated with a customer that declared bankruptcy during the first quarter of 2020.

34

Restructuring expenses and asset impairments of $127 in 2021 related to additional severance liabilities for employees terminated as part of closing manufacturing operations in France in 2018. Expenses of $264 in 2020 related to severance costs.

Operating income increased $2,654 compared with 2020 primarily due to improved project mix, the favorable impact of higher sales volume on fixed expenses, and receipt of $1,958 ERC under the CARES Act.

Adjusted EBITDA increased compared with 2020 primarily due to the factors discussed above. See “Overview” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.

	Nine months ended September 30,
	2021	2020
Operating income	8,595	5,941
Adjustments:
Restructuring expenses and asset impairments	127	264
Adjusted operating income	8,722	6,205
Depreciation	2,479	2,306
Amortization of purchased intangibles	372	288
Adjusted EBITDA	11,573	8,799

Liquidity and Capital Resources

We have historically financed our operations from a combination of internally generated cash flow, revolving credit borrowings, and various long-term debt arrangements. The COVID-19 pandemic drove a sharp decline in DynaEnergetics' core oil and gas end markets and corresponding well-completion activity and demand for its perforating systems late in the first quarter of 2020. In April 2020, DMC announced several cost-containment actions to reduce our activity-based cost structure, limit spending and protect our balance sheet. These actions included reducing our workforce by 32%, implementing reduced work weeks at DynaEnergetics, significantly cutting selling, general and administrative expenses, reducing our capital expenditures budget by 50% and suspending the quarterly dividend. While the decline in crude oil prices and oil and gas demand accelerated early in the second quarter of 2020, sales volume has improved in the four consecutive quarters through the third quarter of 2021. Though NobelClad customers in the downstream energy industry have delayed various projects, NobelClad’s order backlog increased to $42,867 at September 30, 2021 from $39,884 at December 31, 2020.

We have also taken action to allow flexibility in accessing the capital markets. On October 22, 2020, we commenced an at-the-market equity program under a shelf registration statement filed in May 2020, which allows us to sell and issue up to $75 million in shares of our common stock from time to time, and since the inception of the program during the fourth quarter of 2020 we have sold 1,006,180 shares of common stock for net proceeds of $51,002. In connection with the commencement of the at-the-market equity program, we also amended our credit facility to waive the requirement to repay outstanding amounts under the credit facility with proceeds from the program. Our ability to access remaining capital may be limited by market conditions at the time of any future potential sale. While we were able to sell shares during the fourth quarter of 2020 and first quarter of 2021, there can be no assurance that any future capital will be available on acceptable terms or at all.

Additionally, on May 3, 2021, the Company announced a registered public offering of its stock under an automatic shelf registration statement on Form S-3ASR filed on May 3, 2021. The Company entered into an underwriting agreement with KeyBanc Capital Markets Inc. (“KeyBanc”), as representative of the underwriters (collectively, the “Underwriters”), pursuant to which the Company agreed to sell 2,500,000 shares of its $0.05 par value common stock to the Underwriters. In addition, the Underwriters were granted an option, exercisable within 30 days, to purchase up to an additional 375,000 shares of common stock to cover over-allotments, if any, on the same terms and conditions. On May 7, 2021 DMC issued a total of 2,875,000 shares of its common stock, which included the exercise of the over-allotment option, at a market price of $45 for gross proceeds of $129,375. Net proceeds from the offering were $123,461, after deducting underwriter fees and other expenses of $5,914. We intend to use the net proceeds from the offering for general corporate purposes, which may include acquisitions. Pending use of the proceeds as described, we invested the proceeds of the offering in highly liquid marketable securities, including commercial paper and U.S. Treasury securities. Please see discussion of our marketable securities in Note 2 to the Condensed Consolidated Financial Statements.

35

These measures enabled us to improve our net cash position from $42,659 at December 31, 2020 to $181,952 at September 30, 2021, maintain our fully undrawn and available $50,000 revolving credit facility, and repay our capital expenditure term loan in full.

We believe that cash and cash equivalents and marketable securities on hand, cash flow from operations, funds available under our current credit facilities and any future replacement thereof, and potential proceeds from our at-the-market offering, will be sufficient to fund the working capital, debt service, if applicable, and other capital expenditure requirements of our current business operations for the foreseeable future. We may also execute capital markets transactions to raise additional funds if we believe market conditions are favorable. Nevertheless, our ability to generate sufficient cash flows from operations will depend upon our success in executing our strategies. If we are unable to (i) realize sales from our backlog; (ii) secure new customer orders; (iii) continue selling products at profitable margins; and (iv) continue to implement cost-effective internal processes, our ability to meet cash requirements through operating activities could be impacted. Furthermore, any restriction on the availability of borrowings under our credit facilities could negatively affect our ability to meet future cash requirements. We will continue to monitor the continuing unprecedented financial and market conditions, including the impacts COVID-19 will have on credit availability and capital markets. We also continue to pursue potential acquisitions; the completion of any acquisition may significantly increase our capital requirements.

Debt facilities

As of September 30, 2021 we had no outstanding borrowings under our credit facility. On March 8, 2018, we entered into a five-year $75,000 credit facility which replaced in its entirety our prior syndicated credit facility entered into on February 23, 2015. The credit facility allows for revolving loans of up to $50,000 with a $20,000 US dollar equivalent sublimit for alternative currency loans. In addition, the agreement provides for a $25,000 Capex Facility which was used to assist in financing our DynaEnergetics manufacturing expansion project in Blum, Texas. At the end of year one, the Capex Facility converted to a term loan which was amortizable at 12.5% of principal per year with a balloon payment for the outstanding balance upon the credit facility maturity date in 2023. In February 2021, we repaid the outstanding Capex Facility balance of $11,750.

The facility has a $100,000 accordion feature to increase the commitments under the revolving loan class and/or to add a term loan subject to approval by applicable lenders. We entered into the credit facility with a syndicate of three banks, with KeyBank, N.A. acting as administrative agent. The syndicated credit facility is secured by the assets of DMC including accounts receivable, inventory, and fixed assets, as well as guarantees and share pledges by DMC and its subsidiaries.

Borrowings under the $50,000 revolving loan can be in the form of one-, two-, three-, or six-month LIBOR loans. Additionally, US dollar borrowings on the revolving loan can be in the form of Base Rate loans (Base Rate borrowings are based on the greater of the administrative agent’s Prime rates, an adjusted Federal Funds rate or an adjusted LIBOR rate). LIBOR loans bear interest at the applicable LIBOR rate plus an applicable margin (varying from 1.50% to 3.00%). Base Rate loans bear interest at the defined Base rate plus an applicable margin (varying from 0.50% to 2.00%).

Borrowings under the $20,000 Alternate Currency sublimit can be in euros, Canadian dollars, pounds sterling, and in any other currency acceptable to the administrative agent. Alternative currency borrowings denominated in euros, pounds sterling, and any other currency that is dealt with on the London Interbank Deposit Market shall be comprised of LIBOR loans and bear interest at the LIBOR rate plus an applicable margin (varying from 1.50% to 3.00%).

As of September 30, 2021 our available borrowing capacity was $50,000. Future borrowings are subject to compliance with financial covenants that could significantly limit such availability.

As of September 30, 2021, there were two significant financial covenants under our credit facility, a debt-to-EBITDA leverage ratio (“leverage ratio”) and a minimum liquidity ratio. The leverage ratio is defined in the credit facility for any trailing four quarter period as the ratio of Consolidated Funded Indebtedness (as defined in the agreement) on the last day of such period to Consolidated Pro Forma EBITDA for such period. For the September 30, 2021 reporting period, the maximum leverage ratio permitted by our syndicated credit facility was 3.00 to 1.0. The actual leverage ratio as of September 30, 2021, calculated in accordance with the credit facility, as amended, was 0.0 to 1.0.

The debt service coverage ratio, as defined in the credit facility, means, for any period, the ratio of Consolidated Pro Forma EBITDA less the sum of cash dividends, cash income taxes and Consolidated Unfunded Capital Expenditures (as defined in the agreement) to Debt Service Charges (as defined in the agreement). The minimum debt service coverage ratio permitted by our credit facility for the September 30, 2021 reporting period is 1.35 to 1.0. The actual debt service coverage ratio for the trailing twelve months ended September 30, 2021 was 6.0 to 1.0.

36

Our credit facility, as amended, also includes various other covenants and restrictions, certain of which relate to the payment of dividends or other distributions to stockholders, redemption of capital stock, incurrence of additional indebtedness, and mortgaging and pledging or disposition of major assets. As of September 30, 2021, we were in compliance with all financial covenants and other provisions of our debt agreements.

We also maintain a line of credit with a German bank for certain European operations. This line of credit provides a borrowing capacity of €7,000.

Other contractual obligations and commitments

Our long-term debt balance decreased to $0 at September 30, 2021 from $8,139 at December 31, 2020. Our other contractual obligations and commitments have not materially changed since December 31, 2020.

Cash flows (used in) provided by operating activities

Net cash used in operating activities was $1,906 for the nine months ended September 30, 2021 compared with net cash provided by operating activities of $21,354 in the same period last year. The decrease primarily was due to an increased use of cash for working capital, which included higher accounts receivable, higher inventory levels to mitigate global supply chain bottlenecks and in anticipation of increased sales activity in future periods, and higher prepaid expenses and other assets related in part to payments to fund our Non-Qualified Deferred Compensation Plan and other prepaid service contracts. The increases in working capital were partially offset by higher accounts payable and accrued expenses resulting from increased purchasing activity.

Cash flows used in investing activities

Net cash flows used in investing activities for the nine months ended September 30, 2021 of $124,514 primarily related to investment in marketable securities of $123,984, using the proceeds from our May 2021 equity offering, and acquisitions of property, plant and equipment partially offset by proceeds from maturities of marketable securities of $4,799 from U.S. treasuries that were converted to cash upon maturity. Net cash flows used in investing activities for the nine months ended September 30, 2020 were $9,662 and related to the acquisitions of property, plant and equipment at DynaEnergetics.

Cash flows provided by (used in) financing activities

Net cash flows provided by financing activities for the nine months ended September 30, 2021 of $134,750 included net proceeds from our equity offering of $123,461 and our ATM equity program of $25,262 partially offset by repayment in full of the Capex Facility of $11,750 and treasury stock purchases of $2,476. Net cash flows used in financing activities for the nine months ended September 30, 2020 of $7,038 was due to dividend payments, treasury stock purchases, and repayments on the Capex Facility.

Payment of Dividends

We paid a quarterly cash dividend of $0.125 per share in the first quarter of 2020. In April 2020, we suspended the quarterly dividend indefinitely due to the uncertain economic outlook caused by the COVID-19 pandemic. Future dividends may be affected by, among other items, our views on potential future capital requirements, future business prospects, debt covenant compliance considerations, changes in income tax laws, and any other factors that our Board of Directors deems relevant. Any determination to pay cash dividends will be at the discretion of the Board of Directors.

Critical Accounting Policies

Our critical accounting policies have not changed from those reported in our Annual Report on Form 10-K for the year ended December 31, 2020.

ITEM 3.  Quantitative and Qualitative Disclosure about Market Risk

There were no material changes in market risk for changes in foreign currency exchange rates and interest rates from the information provided in Item 7A – Quantitative and Qualitative Disclosures About Market Risk in the company's Annual Report on Form 10-K for the year ended December 31, 2020.

37

ITEM 4.  Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer have evaluated the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report, and they have concluded that these controls and procedures are effective.

Changes in Internal Control over Financial Reporting

There were no changes that occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

38

Part II - OTHER INFORMATION

Item 1. Legal Proceedings

Please see Note 12 to the Condensed Consolidated Financial Statements.

Item 1A. Risk Factors

There have been no significant changes in the risk factors identified as being attendant to our business in our Annual Report on Form 10-K for the year ended December 31, 2020, except as provided below.

The proposed new regulation concerning mandatory COVID-19 vaccination of employees could have a material adverse impact on our business and results of operations.

On September 9, 2021, President Biden announced a proposed new rule requiring all employers with at least 100 employees to ensure that their employees are fully vaccinated or require unvaccinated workers to get a negative test at least once a week. The Department of Labor's Occupational Safety and Health Administration (“OSHA”) is drafting an emergency regulation to carry out this mandate, which is expected to take effect in the coming weeks. We currently have no details as to the requirements of the regulations, and it is not possible to predict with certainty the impacts the new regulation would have on us. As a company with more than 100 employees, we would be required to mandate COVID-19 vaccination of our workforce or require our unvaccinated employees to be tested on a weekly basis. This may result in increased costs, labor disruptions or employee attrition, which could be material as a substantial number of our employees are based in areas of the country where vaccination rates are below the national average. If we lose employees, it will be difficult in the current competitive labor market to find replacement employees, and this could have an adverse effect on future revenues and costs, which could be material. In addition, additional uncertainty could be caused by competing and potentially conflicting laws and regulations, such as the recent executive order issued by the governor of Texas prohibiting vaccine mandates. Accordingly, the proposed new OSHA regulation when implemented could have a material adverse effect on our business and results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

In connection with the vesting of Company restricted common stock under our equity incentive plans during the third quarter of 2021, we retained shares of common stock in satisfaction of withholding tax obligations. These shares are held as treasury shares by the Company.

	Total number of shares purchased (1) (2)	Average price paid per share
July 1 to July 31, 2021	64	$	56.21
August 1 to August 31, 2021	43,661	$	41.31
September 1 to September 30, 2021	320	$	39.38
Total	44,045	$	41.32

(1) Share purchases in 2021 included 177 shares withheld to offset tax withholding obligations that occurred upon the vesting of restricted common stock under the terms of the 2016 Equity Incentive Plan and 43,368 share purchases related to the participant elections to diversify contributions of equity awards into other investment options available to participants in the Company’s Amended and Restated Non-Qualified Deferred Compensation Plan.

(2) As of September 30, 2021, the maximum number of shares that may yet be purchased would not exceed the employees’ portion of taxes withheld on unvested shares (295,261) and potential purchases upon participant elections to diversify equity awards held in the Company’s Amended and Restated Non-Qualified Deferred Compensation Plan (142,565) into other investment options available to participants in the Plan.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Our Coolspring property is subject to regulation by the Federal Mine Safety and Health Administration (“MSHA”) under the Federal Mine Safety and Health Act of 1977 (the “Mine Act”). Pursuant to Section 1503(a) of the Dodd-Frank Wall Street

39

Reform and Consumer Protection Act (The “Dodd-Frank Act”), issuers that are operators, or that have a subsidiary that is an operator, of a coal or other mine in the United States are required to disclose in their periodic reports filed with the SEC information regarding specified health and safety violations, orders and citations, related assessments and legal actions, and mining-related fatalities. During the quarter ended September 30, 2021, we had no such specified health and safety violations, orders or citations, related assessments or legal actions, mining-related fatalities, or similar events in relation to our United States operations requiring disclosure pursuant to Section 1503(a) of the Dodd-Frank Act.

Item 5. Other Information

None.

Item 6. Exhibits

31.1 Certification of the President and Chief Executive Officer pursuant to 17 CFR 240.13a-14(a) or 17 CFR 240.15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2 Certification of the Chief Financial Officer pursuant to 17 CFR 240.13a-14(a) or 17 CFR 240.15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1 Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2 Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101 The following materials from the Quarterly Report on Form 10-Q of DMC Global Inc. for the quarter ended September 30, 2021, formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statement of Stockholders’ Equity, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) the Notes to Condensed Consolidated Financial Statements, tagged as blocks of text.*

*    Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

		DMC Global Inc.
		(Registrant)
Date:	October 21, 2021	/s/ Michael Kuta
		Michael Kuta, Chief Financial Officer (Duly Authorized Officer and Principal Financial and Accounting Officer)

40

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Kevin T. Longe, certify that:

1. I have reviewed this quarterly report on Form 10-Q of DMC Global Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  October 21, 2021

/s/ Kevin T. Longe

Kevin T. Longe

President and Chief Executive Officer

of DMC Global Inc.

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Michael Kuta, certify that:

1. I have reviewed this quarterly report on Form 10-Q of DMC Global Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  October 21, 2021

/s/ Michael Kuta

Michael Kuta

Chief Financial Officer of DMC Global Inc.

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of DMC Global Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kevin T. Longe, President and Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to  Section 906 of the Sarbanes-Oxley Act of 2002, that:

(i) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

October 21, 2021

/s/ Kevin T. Longe

Kevin T. Longe

President and Chief Executive Officer

of DMC Global Inc.

A signed original of this written statement required by Section 906 has been provided to DMC Global Inc. and will be retained by DMC Global Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of DMC Global Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Kuta, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(i) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

October 21, 2021

/s/ Michael Kuta

Michael Kuta

Chief Financial Officer of DMC Global Inc.

A signed original of this written statement required by Section 906 has been provided to DMC Global Inc. and will be retained by DMC Global Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	9 Months Ended
	Sep. 30, 2021	Oct. 21, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-14775
Entity Registrant Name	DMC GLOBAL INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-0608431
Entity Address, Address Line One	11800 Ridge Parkway
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Broomfield
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80021
City Area Code	303
Local Phone Number	665-5700
Title of 12(b) Security	Common Stock, $0.05 Par Value
Trading Symbol	BOOM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		18,724,831
Entity Central Index Key	0000034067
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 37,020	$ 28,187
Marketable securities	144,932	25,736
Accounts receivable, net of allowance for doubtful accounts of $2,693 and $2,605, respectively	39,347	31,366
Inventories	62,172	52,573
Prepaid expenses and other	9,974	5,448
Total current assets	293,445	143,310
Property, plant and equipment	172,039	180,278
Less - accumulated depreciation	(66,902)	(70,867)
Property, plant and equipment, net	105,137	109,411
Purchased intangible assets, net	1,829	3,665
Deferred tax assets	5,747	4,582
Other assets	30,217	18,677
Total assets	436,375	279,645
Current liabilities:
Accounts payable	24,436	17,574
Accrued expenses	7,459	5,301
Accrued income taxes	8,101	7,279
Accrued employee compensation and benefits	8,585	7,160
Contract liabilities	9,759	4,928
Current portion of long-term debt	0	3,125
Other current liabilities	1,648	1,741
Total current liabilities	59,988	47,108
Long-term debt	0	8,139
Deferred tax liabilities	1,373	2,254
Other long-term liabilities	30,114	25,230
Total liabilities	91,475	82,731
Commitments and contingencies (Note 12)
Stockholders’ equity
Preferred stock, $0.05 par value; 4,000,000 shares authorized; no issued and outstanding shares	0	0
Common stock, $0.05 par value; 25,000,000 shares authorized; 19,294,745 and 15,917,559 shares issued, respectively	965	796
Additional paid-in capital	270,993	117,387
Retained earnings	118,216	115,657
Other cumulative comprehensive loss	(25,803)	(22,962)
Treasury stock, at cost, and company stock held for deferred compensation, at par; 569,914 and 528,274 shares, respectively	(19,471)	(13,964)
Total stockholders’ equity	344,900	196,914
Total liabilities and stockholders’ equity	$ 436,375	$ 279,645

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 2,693	$ 2,605
Preferred stock, par value (in dollars per share)	$ 0.05	$ 0.05
Preferred stock, authorized (in shares)	4,000,000	4,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, authorized (in shares)	25,000,000	25,000,000
Common stock, issued (in shares)	19,294,745	15,917,559
Treasury stock (in shares)	569,914	528,274

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net sales	$ 67,175	$ 55,281	$ 188,271	$ 172,048
Cost of products sold	50,513	41,688	141,725	127,381
Gross profit	16,662	13,593	46,546	44,667
Costs and expenses:
General and administrative expenses	9,721	6,911	26,121	21,744
Selling and distribution expenses	5,593	4,705	16,380	18,720
Amortization of purchased intangible assets	211	369	823	1,076
Restructuring expenses and asset impairments	0	143	127	3,305
Total costs and expenses	15,525	12,128	43,451	44,845
Operating income (loss)	1,137	1,465	3,095	(178)
Other income (expense):
Other (expense) income, net	(198)	(148)	304	(118)
Interest expense, net	(14)	(170)	(230)	(564)
Income (loss) before income taxes	925	1,147	3,169	(860)
Income tax provision (benefit)	522	139	610	(375)
Net income (loss)	$ 403	$ 1,008	$ 2,559	$ (485)
Net income (loss) per share
Basic (in dollars per share)	$ 0.02	$ 0.07	$ 0.15	$ (0.03)
Diluted (in dollars per share)	$ 0.02	$ 0.07	$ 0.15	$ (0.03)
Weighted average shares outstanding:
Basic (in shares)	18,728,278	14,820,881	17,239,306	14,759,062
Diluted (in shares)	18,739,085	14,820,881	17,250,525	14,759,062
Dividends declared per common share (in dollars per share)	$ 0	$ 0	$ 0	$ 0.125

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 403	$ 1,008	$ 2,559	$ (485)
Change in cumulative foreign currency translation adjustment	(1,347)	753	(2,841)	518
Total comprehensive (loss) income	$ (944)	$ 1,761	$ (282)	$ 33

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Equity Offering	ATM Offering	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Common Stock Equity Offering	Common Stock ATM Offering	Additional Paid-In Capital	Additional Paid-In Capital Equity Offering	Additional Paid-In Capital ATM Offering	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Other Cumulative Comprehensive Loss	Treasury Stock and Company Stock Held for Deferred Compensation
Beginning balances (in shares) at Dec. 31, 2019					15,117,207									464,532
Beginning balances at Dec. 31, 2019	$ 172,141			$ (50)	$ 756			$ 85,639			$ 119,002	$ (50)	$ (25,803)	$ (7,453)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(485)										(485)
Change in cumulative foreign currency translation adjustment	518												518
Shares issued in connection with stock compensation plans (in shares)					183,017
Shares issued in connection with stock compensation plans	266				$ 9			257
Stock-based compensation	4,162							4,162
Dividends declared	(1,883)										(1,883)
Treasury stock activity	(4,718)							11						$ (4,729)
Treasury stock activity (in shares)														(63,505)
Ending balances (in shares) at Sep. 30, 2020					15,300,224									528,037
Ending balances at Sep. 30, 2020	169,951				$ 765			90,069			116,584		(25,285)	$ (12,182)
Beginning balances (in shares) at Jun. 30, 2020					15,297,291									527,981
Beginning balances at Jun. 30, 2020	170,283				$ 765			88,501			115,576		(26,038)	$ (8,521)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	1,008										1,008
Change in cumulative foreign currency translation adjustment	753												753
Shares issued in connection with stock compensation plans (in shares)					2,933
Shares issued in connection with stock compensation plans	3							3
Stock-based compensation	1,554							1,554
Treasury stock activity	(3,650)							11						$ (3,661)
Treasury stock activity (in shares)														(56)
Ending balances (in shares) at Sep. 30, 2020					15,300,224									528,037
Ending balances at Sep. 30, 2020	169,951				$ 765			90,069			116,584		(25,285)	$ (12,182)
Beginning balances (in shares) at Dec. 31, 2020					15,917,559									528,274
Beginning balances at Dec. 31, 2020	196,914				$ 796			117,387			115,657		(22,962)	$ (13,964)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	2,559										2,559
Change in cumulative foreign currency translation adjustment	(2,841)												(2,841)
Shares issued in connection with public offering (in shares)						2,875,000	397,820
Shares issued in connection with public offering		$ 123,461	$ 25,262			$ 144	$ 20		$ 123,317	$ 25,242
Shares issued in connection with stock compensation plans (in shares)					104,366
Shares issued in connection with stock compensation plans	253				$ 5			248
Stock-based compensation	4,799							4,799
Treasury stock activity	(5,507)													$ (5,507)
Treasury stock activity (in shares)														(41,640)
Ending balances (in shares) at Sep. 30, 2021					19,294,745									569,914
Ending balances at Sep. 30, 2021	344,900				$ 965			270,993			118,216		(25,803)	$ (19,471)
Beginning balances (in shares) at Jun. 30, 2021					19,294,745									569,737
Beginning balances at Jun. 30, 2021	346,037				$ 965			269,375			117,813		(24,456)	$ (17,660)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	403										403
Change in cumulative foreign currency translation adjustment	(1,347)												(1,347)
Stock-based compensation	1,618							1,618
Treasury stock activity	(1,811)													$ (1,811)
Treasury stock activity (in shares)														(177)
Ending balances (in shares) at Sep. 30, 2021					19,294,745									569,914
Ending balances at Sep. 30, 2021	$ 344,900				$ 965			$ 270,993			$ 118,216		$ (25,803)	$ (19,471)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows provided by operating activities:
Net income (loss)	$ 2,559	$ (485)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation	8,400	7,167
Amortization of purchased intangible assets	823	1,076
Amortization of deferred debt issuance costs	168	154
Stock-based compensation	4,904	4,154
Deferred income taxes	(2,046)	(839)
(Gain) loss on disposal of property, plant and equipment	(298)	113
Restructuring expenses and asset impairments	127	3,305
Change in:
Accounts receivable, net	(8,562)	26,890
Inventories	(10,620)	(2,228)
Prepaid expenses and other	(15,892)	(2,855)
Accounts payable	6,861	(10,563)
Contract liabilities	4,957	2,376
Accrued expenses and other liabilities	6,713	(6,911)
Net cash (used in) provided by operating activities	(1,906)	21,354
Cash flows used in investing activities:
Investment in marketable securities	(123,984)	0
Proceeds from maturities of marketable securities	4,799	0
Acquisition of property, plant and equipment	(6,348)	(9,682)
Proceeds on sale of property, plant and equipment	1,019	20
Net cash used in investing activities	(124,514)	(9,662)
Cash flows provided by (used in) financing activities:
Repayments on capital expenditure facility	(11,750)	(2,344)
Payment of dividends	0	(3,749)
Payment of debt issuance costs	0	(88)
Net proceeds from issuance of common stock to employees and directors	253	266
Treasury stock purchases	(2,476)	(1,123)
Net cash provided by (used in) financing activities	134,750	(7,038)
Effects of exchange rates on cash	503	(403)
Net increase in cash and cash equivalents	8,833	4,251
Cash and cash equivalents, beginning of the period	28,187	20,353
Cash and cash equivalents, end of the period	37,020	24,604
Equity Offering
Cash flows provided by (used in) financing activities:
Proceeds from issuance of common stock offering	123,461	0
ATM Offering
Cash flows provided by (used in) financing activities:
Proceeds from issuance of common stock offering	$ 25,262	$ 0

XML

BASIS OF PRESENTATION

9 Months Ended

Sep. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION

BASIS OF PRESENTATION

The information included in the condensed consolidated financial statements is unaudited but includes all normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the interim periods presented. Certain information and footnote disclosures, including critical and significant accounting policies normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted for this quarterly presentation. These condensed consolidated financial statements should be read in conjunction with the financial statements that are included in our Annual Report filed on Form 10-K for the year ended December 31, 2020.

XML

SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The condensed consolidated financial statements include the accounts of DMC Global Inc. (“DMC”, “we”, “us”, “our”, or the “Company”) and its controlled subsidiaries. Only subsidiaries in which controlling interests are maintained are consolidated. All significant intercompany accounts, profits, and transactions have been eliminated in consolidation.

Marketable Securities

We typically invest in highly rated securities with the primary objectives of preserving principal, providing access to liquidity to fund the ongoing operations and strategic needs of the Company and its subsidiaries, and achieving a yield that is commensurate with low risk and highly liquid securities.

Our investments in marketable debt securities are classified as either trading, available-for-sale or held-to-maturity based on the nature of the securities and their availability for use in current operations. The Company classifies its marketable debt securities in the Condensed Consolidated Balance Sheet as current or non-current based on related maturities and expectations of sales and redemptions in the subsequent twelve-month period. The Company may sell certain of its marketable debt securities prior to their stated maturities to manage liquidity, credit risk, or asset allocation.

As of September 30, 2021 and December 31, 2020, our investments had maturities ranging from three to twelve months, and all such investments have been classified and accounted for as trading securities.

The Company’s investments in marketable securities consisted of the following:

	September 30, 2021		December 31, 2020
U.S. Treasury securities	$	76,591	$	25,736
Commercial paper (A-1 or P-1 rated)	68,341		—
Marketable securities	$	144,932	$	25,736

The Company’s U.S. Treasury securities have annual yields between 0.01% and 0.04% and the commercial paper securities have annual yields between 0.09% and 0.10%. The Company’s investments in marketable securities are measured at fair value with gains and losses recognized in the Condensed Consolidated Statement of Operations within “Other (expense) income, net." For the three and nine months ended September 30, 2021, the net gains on marketable securities were $2 and $12, respectively.

Accounts and Notes Receivable

The Company measures expected credit losses for its accounts receivable using a current expected credit loss model, which is based on historical experience, adjusted for current conditions and reasonable and supportable forecasts. The Company has disaggregated pools of accounts receivable balances by business, geography and/or customer risk profile and has used

history and other experience to establish an allowance for credit losses at the time the receivable is recognized. To measure expected credit losses, we have elected to pool trade receivables by segment and analyze DynaEnergetics and NobelClad accounts receivable balances as separate populations. Within each segment, receivables exhibit similar risk characteristics.

During the three and nine months ended September 30, 2021, our expected loss rate continued to reflect uncertainties in market conditions present in both of our businesses due to the ongoing COVID-19 pandemic. In addition, we reviewed receivables outstanding, including aged balances, and in circumstances where we are aware of a specific customer’s inability to meet its financial obligation to us, we recorded a specific allowance for credit losses (with the offsetting expense charged to “Selling and distribution expenses” in our Condensed Consolidated Statements of Operations) against the amounts due, reducing the net recognized receivable to the amount we estimate will be collected. During the three and nine months ended September 30, 2021, provisions of $4 and $100, respectively, were recorded.

The following table summarizes year-to-date activity in the allowance for credit losses on receivables from DynaEnergetics and NobelClad customers:

	DynaEnergetics		NobelClad		DMC Global Inc.
Allowance for doubtful accounts, December 31, 2020	$	2,590	$	15	$	2,605
Current period provision for expected credit losses	100		—		100
Recoveries of amounts previously reserved	(10)		—		(10)
Impacts of foreign currency exchange rates and other	(2)		—		(2)
Allowance for doubtful accounts, September 30, 2021	$	2,678	$	15	$	2,693

During the third quarter of 2021, the Company entered into a note receivable with terms of repayment over five years, collateralized by certain fixed assets. The note, with an outstanding current balance of $622 as of September 30, 2021 recorded within “Prepaid expenses and other” and an outstanding long-term balance of $4,995 as of September 30, 2021 recorded within “Other Assets”, is considered an arrangement with a variable interest entity for which the Company is not the primary beneficiary and has concluded does not require consolidation.

Revenue Recognition

The Company’s revenues are primarily derived from consideration paid by customers for tangible goods. The Company analyzes its different goods by segment to determine the appropriate basis for revenue recognition. Revenue is not generated from sources other than contracts with customers and revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. There are no material upfront costs for operations that are incurred from contracts with customers.

Our rights to payments for goods transferred to customers arise when control is transferred at a point in time and not on any other criteria. Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 60 days. In instances when we require customers to make advance payments prior to the shipment of their orders, we record a contract liability. We have determined that our contract liabilities do not include a significant financing component given the short duration between order initiation and order fulfillment within each of our segments. Please refer to Note 5 “Contract Liabilities” for further information on contract liabilities and Note 10 “Business Segments” for disaggregated revenue disclosures.

Income Taxes

We recognize deferred tax assets and liabilities for the expected future income tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities. Any effects of changes in income tax rates or tax laws are included in the provision for income taxes in the period of enactment. The deferred income tax impact of tax credits is recognized as an immediate adjustment to income tax expense. We recognize deferred tax assets for the expected future effects of all deductible temporary differences to the extent we believe these assets will more likely than not be realized. We record a valuation allowance when, based on current circumstances, it is more likely than not that all or a portion of the deferred tax assets will not be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, recent financial operations and their associated valuation allowances, if any.

We recognize the tax benefits from uncertain tax positions only when it is more likely than not, based on the technical merits of the position that it will be sustained upon examination, including the resolution of any related appeals or litigation. The tax benefits recognized in the consolidated financial statements from such a position are measured as the largest benefit that is more likely than not to be realized upon ultimate resolution. We recognize interest and penalties related to uncertain tax positions in operating expense.

Earnings Per Share

In periods with net income, the Company computes earnings per share (“EPS”) using a two-class method, which is an earnings allocation formula that determines EPS for (i) each class of common stock (the Company has a single class of common stock), and (ii) participating securities according to dividends declared and participation rights in undistributed earnings. Restricted stock awards are considered participating securities in periods of net income as they receive non-forfeitable rights to dividends similar to common stock. Restricted stock awards do not participate in net losses.

Basic EPS is calculated by dividing net income available to common stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS adjusts basic EPS for the effects of restricted stock awards, performance share units and other potentially dilutive financial instruments (dilutive securities), only in the periods in which such effect is dilutive. The effect of the dilutive securities is reflected in diluted EPS by application of the more dilutive of (1) the treasury stock method or (2) the two-class method. For the periods presented, diluted EPS using the treasury stock method was less dilutive than the two-class method; as such, only the two-class method has been included below.

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net income (loss), as reported	$	403	$	1,008	2,559		(485)
Less: Undistributed net income available to participating securities	(3)		(17)		(25)		—
Numerator for basic net income (loss) per share:	400		991		2,534		(485)
Add: Undistributed net income allocated to participating securities	3		17		25		—
Less: Undistributed net income reallocated to participating securities	(3)		(17)		(25)		—
Numerator for diluted net income (loss) per share:	400		991		2,534		(485)
Denominator:
Weighted average shares outstanding for basic net income (loss) per share	18,728,278		14,820,881		17,239,306		14,759,062
Effect of dilutive securities (1)	10,807		—		11,219		—
Weighted average shares outstanding for diluted net income (loss) per share	18,739,085		14,820,881		17,250,525		14,759,062
Net income (loss) per share
Basic	$	0.02	$	0.07	$	0.15	$	(0.03)
Diluted	$	0.02	$	0.07	$	0.15	$	(0.03)

(1) For the three and nine months ended September 30, 2020, 30,967 and 19,394 respectively, shares have been excluded as their effect would have been anti-dilutive.

Deferred compensation

The Company maintains a Non-Qualified Deferred Compensation Plan (the “Plan”) as part of its overall compensation package for certain employees. Participants are eligible to defer a portion of their annual salary, their annual incentive bonus, and their equity awards through the Plan on a tax-deferred basis. Deferrals into the Plan are not matched or subsidized by the Company, nor are they eligible for above-market or preferential earnings.

The Plan provides for deferred compensation obligations to be settled either by delivery of a fixed number of shares of DMC’s common stock or in cash, in accordance with participant contributions and elections. For deferred equity awards, subsequent to equity award vesting and after a period prescribed by the Plan, participants can elect to diversify contributions of equity awards into other investment options available to Plan participants. Once diversified, contributions of equity awards will be settled by delivery of cash.

The Company has established a grantor trust commonly known as a “rabbi trust” and contributed certain assets to satisfy the future obligations to participants in the Plan. These assets are subject to potential claims of the Company’s general creditors. The assets held in the trust include unvested restricted stock awards (“RSAs”), vested company stock awards, company-owned life insurance (“COLI”) on certain employees, and money market and mutual funds. Unvested RSAs and common stock held by the trust are reflected in the Consolidated Balance Sheets within “Treasury stock, at cost, and company stock held for deferred compensation, at par” at the par value of the common stock or unvested RSAs. These accounts are not adjusted for subsequent changes in the fair value of the common stock. COLI is accounted for at the cash surrender value while money market and mutual funds held by the trust are accounted for at fair value.

Deferred compensation obligations that will be settled in cash are accounted for on an accrual basis in accordance with the terms of the Plan. These obligations are adjusted based on changes in value of the underlying investment options chosen by Plan participants. Deferred compensation obligations that will be settled by delivery of a fixed number of previously vested shares of the Company’s common stock are reflected in the Consolidated Statements of Stockholders’ Equity within “Common stock” at the par value of the common stock or unvested RSAs. These accounts are not adjusted for subsequent changes in the fair value of the common stock.

The balances related to the deferred compensation plan were as follows:

	Consolidated Balance Sheet location	September 30, 2021		December 31, 2020
Deferred compensation assets	Other assets	$	13,261	$	7,596
Deferred compensation obligations	Other long-term liabilities	$	15,695	$	11,894

Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We are required to use an established hierarchy for fair value measurements based upon the inputs to the valuation and the degree to which they are observable or not observable in the market. The three levels in the hierarchy are as follows:                   

•Level 1 — Inputs to the valuation based upon quoted prices (unadjusted) for identical assets or liabilities in active markets that are accessible as of the measurement date.

•Level 2 — Inputs to the valuation include quoted prices in either markets that are not active, or in active markets for similar assets or liabilities, inputs other than quoted prices that are observable, and inputs that are derived principally from or corroborated by observable market data.

•Level 3 — Inputs to the valuation that are unobservable inputs for the asset or liability. 

The highest priority is assigned to Level 1 inputs and the lowest priority to Level 3 inputs.

The carrying value of accounts receivable and payable, accrued expenses, revolving loans under our credit facility and borrowings under our capital expenditure facility, when outstanding, approximate their fair value.

Our U.S. Treasury marketable securities are valued using quoted prices in active markets that are accessible as of the measurement date. Our revolving loans and borrowings under our capital expenditure facility, when outstanding, reset each month at market interest rates. Money market funds and mutual funds of $8,629 as of September 30, 2021 and $4,244 as of December 31, 2020 held to satisfy future deferred compensation obligations are valued based upon the market values of underlying securities. We classify these assets as Level 1 in the fair value hierarchy.

Our commercial paper marketable securities are valued using quoted market prices in non-active markets. Our foreign currency forward contracts are also valued using quoted market prices in non-active markets or are determined using a yield curve model based on current market rates. As a result, we classify commercial paper marketable securities and foreign currency forward contracts as Level 2 in the fair value hierarchy.

We did not hold any Level 3 assets or liabilities as of September 30, 2021 or December 31, 2020.

Recent Accounting Pronouncements

In December 2019, the Financial Accounting Standards Board issued a new accounting pronouncement regarding accounting for income taxes. The new standard removes certain exceptions to the general principles in ASC 740 Income Taxes and also clarifies and amends existing guidance to provide for more consistent application. The new standard became effective for the Company in the first quarter of fiscal 2021 and did not have a material impact on our consolidated financial statements.

XML

INVENTORIES

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

INVENTORIES

INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Significant cost elements included in inventory are material, labor, freight, subcontract costs, and manufacturing overhead. As necessary, we adjust inventory to its net realizable value by recording provisions for excess, slow moving and obsolete inventory. We regularly review inventory quantities on hand and values, and compare them to estimates of future product demand, market conditions, production requirements and technological developments.

Inventories consisted of the following at September 30, 2021:

	DynaEnergetics		NobelClad		DMC Global Inc.
Raw materials	$	13,865	$	8,923	$	22,788
Work-in-process	13,486		6,808		20,294
Finished goods	18,251		634		18,885
Supplies	—		205		205
Inventories	$	45,602	$	16,570	$	62,172

Inventories consisted of the following at December 31, 2020:

	DynaEnergetics		NobelClad		DMC Global Inc.
Raw materials	$	13,250	$	11,903	$	25,153
Work-in-process	7,062		6,682		13,744
Finished goods	12,806		669		13,475
Supplies	—		201		201
Inventories	$	33,118	$	19,455	$	52,573

XML

PURCHASED INTANGIBLE ASSETS

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

PURCHASED INTANGIBLE ASSETS

PURCHASED INTANGIBLE ASSETS

Our purchased intangible assets consisted of the following as of September 30, 2021:

	Gross		Accumulated Amortization		Net
Core technology	$	16,052	$	(14,223)	$	1,829
Customer relationships	36,110		(36,110)		—
Trademarks / Trade names	2,069		(2,069)		—
Total intangible assets	$	54,231	$	(52,402)	$	1,829

Our purchased intangible assets consisted of the following as of December 31, 2020:

	Gross		Accumulated Amortization		Net
Core technology	$	17,899	$	(14,234)	$	3,665
Customer relationships	37,638		(37,638)		—
Trademarks / Trade names	2,194		(2,194)		—
Total intangible assets	$	57,731	$	(54,066)	$	3,665

The change in the gross value of our purchased intangible assets from December 31, 2020 to September 30, 2021 was due to foreign currency translation and the recognition of the tax benefit of tax deductible goodwill amortization related to the 2007 acquisition of our German subsidiaries. Prior to the impairment of the goodwill related to the NobelClad and DynaEnergetics reporting units at September 30, 2017 and December 31, 2015, respectively, the tax benefit of tax amortization

reduced the goodwill balance. After we fully impaired the goodwill, which is only written off for U.S. GAAP purposes, the tax benefit of tax goodwill amortization reduces the gross value of the purchased intangible assets related to this acquisition.

XML

CONTRACT LIABILITIES

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

CONTRACT LIABILITIES

CONTRACT LIABILITIES

On occasion, we require customers to make advance payments prior to the shipment of goods in order to help finance our inventory investment on large orders or to keep customers’ credit limits at acceptable levels. Contract liabilities were as follows:

	September 30, 2021		December 31, 2020
NobelClad	$	9,450	$	4,450
DynaEnergetics	309		478
Total	$	9,759	$	4,928

We generally expect to recognize the revenue associated with contract liabilities over a time period no longer than one year, but unforeseen circumstances can cause delays in shipments associated with contract liabilities. Approximately 78% of the $4,928 recorded as contract liabilities at December 31, 2020 was recorded to net sales during the nine months ended September 30, 2021.

XML

LEASES

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

LEASES

LEASES

The Company leases real properties for use in manufacturing and as administrative and sales offices, and also leases automobiles and office equipment. The Company determines if a contract contains a lease arrangement at the inception of the contract. For leases in which the Company is the lessee, leases are classified as either finance or operating. Right of use (ROU) assets are initially measured at the present value of lease payments over the lease term plus initial direct costs, if any, with the classification affecting the pattern of expense recognition. If a lease does not provide a discount rate and the rate cannot be readily determined, an incremental borrowing rate is used to determine the future lease payments. Lease and non-lease components within the Company’s lease agreements are accounted for together.

Nearly all of the Company’s leasing arrangements are classified as operating leases. ROU asset and lease liability balances were as follows for the periods presented:

	September 30, 2021		December 31, 2020
ROU asset	$	11,198	$	10,733
Current lease liability	1,648		1,741
Long-term lease liability	10,432		10,066
Total lease liability	$	12,080	$	11,807

The ROU asset was included in “Other assets” while the current lease liability was reported in “Other current liabilities” and the long-term lease liability was reported in “Other long-term liabilities” in the Company’s Condensed Consolidated Balance Sheet. Cash paid for operating lease liabilities are recorded as cash flows from operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. For the three months ended September 30, 2021 and 2020, operating lease costs were $1,064 and $1,055, respectively. For the nine months ended September 30, 2021 and 2020, operating lease costs were $3,074 and $3,051, respectively. Operating lease costs were included in the Company’s Condensed Consolidated Statements of Operations. Short term and variable lease costs were not material for the three and nine months ended September 30, 2021 and 2020.

Certain of the Company’s leases contain renewal options and options to extend the leases for up to five years, and a majority of these options are reflected in the calculation of the ROU asset and lease liability due to the likelihood of renewal.

The following table summarizes the weighted average lease terms and discount rates for operating lease liabilities:

	September 30, 2021
Weighted average remaining lease term (in years)	7.71
Weighted average discount rate	5.4	%

The following table represents maturities of operating lease liabilities as of September 30, 2021:

Due within 1 year	$	1,648
Due after 1 year through 2 years	2,379
Due after 2 years through 3 years	2,160
Due after 3 years through 4 years	2,019
Due after 4 years through 5 years	1,642
Due after 5 years	5,067
Total future minimum lease payments	14,915
Less imputed interest	(2,835)
Total	$	12,080

XML

DEBT

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

DEBT

DEBT

As of September 30, 2021 we had no outstanding borrowings under our credit facility. As of December 31, 2020, outstanding borrowings consisted of the following:

Syndicated credit agreement:
Capital expenditure facility	$	11,750
Outstanding borrowings	11,750
Less: debt issuance costs	(486)
Total debt	11,264
Less: current portion of long-term debt	(3,125)
Long-term debt	$	8,139

Syndicated Credit Agreement

On March 8, 2018, we entered into a five-year $75,000 syndicated credit agreement (“credit facility”) which replaced in its entirety our prior syndicated credit facility entered into on February 23, 2015. The credit facility is with a syndicate of three banks, with KeyBank, N.A. acting as administrative agent. The facility is secured by the assets of DMC including accounts receivable, inventory, and fixed assets, as well as guarantees and share pledges by DMC and its subsidiaries. The credit facility allows for revolving loans of up to $50,000 with a $20,000 US dollar equivalent sublimit for alternative currency loans. In addition, the agreement provided for a $25,000 Capital Expenditure Facility (“Capex Facility”) which was used to assist in financing our DynaEnergetics manufacturing expansion project in Blum, Texas. At the end of year one, the Capex Facility converted to a term loan which was amortizable at 12.5% of principal per year with a balloon payment for the outstanding balance upon the credit facility maturity date in 2023. In February 2021, we repaid the remaining Capex Facility balance of $11,750.

The credit facility has a $100,000 accordion feature to increase the commitments under the revolving loan class and/or by adding a term loan subject to approval by applicable lenders.

Borrowings under the $50,000 revolving loan can be in the form of one-, two-, three-, or six-month LIBOR rate loans. Additionally, US dollar borrowings on the revolving loan can be in the form of Base Rate loans (Base Rate borrowings are based on the greater of the administrative agent’s Prime rates, an adjusted Federal Funds rate or an adjusted LIBOR rate). LIBOR loans bear interest at the applicable LIBOR rate plus an applicable margin (varying from 1.50% to 3.00%). Base Rate loans bear interest at the defined Base rate plus an applicable margin (varying from 0.50% to 2.00%).

Borrowings under the $20,000 alternate currency sublimit can be in euros, Canadian dollars, pounds sterling, and in any other currency acceptable to the administrative agent. Alternative currency borrowings denominated in euros, pounds sterling, and any other currency that is dealt with on the London Interbank Deposit Market shall be comprised of LIBOR loans and bear interest at the LIBOR rate plus an applicable margin (varying from 1.50% to 3.00%).

On October 22, 2020, in connection with the commencement of our at-the-market offering, we entered into an amendment to the credit facility to waive the requirement that we repay outstanding balances under the credit facility from the proceeds of any equity offering. The waiver applies to at-the-market offerings up to $75 million.

The credit facility, as amended, includes various covenants and restrictions, certain of which relate to the payment of dividends or other distributions to stockholders; redemption of capital stock; incurrence of additional indebtedness; mortgaging, pledging or disposition of major assets; and maintenance of specified ratios. As of September 30, 2021, we were in compliance with all financial covenants and other provisions of our debt agreements.

We also maintain a line of credit with a German bank for certain European operations. In July 2020, the German Bank Facility was amended to increase the borrowing capacity from €4,000 to €7,000. Of the €7,000 borrowing capacity, €4,000 was available as of September 30, 2021 after considering outstanding letters of credit.

Given that we had no outstanding debt as of September 30, 2021, our deferred debt issuance costs of $318 were reported in the “Other assets” line item in our Condensed Consolidated Balance Sheet. Our deferred debt issuance costs of $486 as of December 31, 2020 were reported in the “Long-term debt” line item in our Condensed Consolidated Balance Sheet. Deferred debt issuance costs are being amortized over the remaining term of the credit facility which expires on March 8, 2023.

XML

EQUITY OFFERINGS AND PROGRAM

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

EQUITY OFFERINGS AND PROGRAM

EQUITY OFFERINGS AND PROGRAM

Equity Offering

On May 3, 2021, the Company announced a registered public offering (“Offering”) of its stock under an automatic shelf registration statement on Form S-3ASR filed on May 3, 2021. The Company entered into an underwriting agreement with KeyBanc Capital Markets Inc. (“KeyBanc”), as representative of the underwriters (collectively, the “Underwriters”), pursuant to which the Company agreed to sell 2,500,000 shares of its $0.05 par value common stock to the Underwriters. In addition, the Underwriters were granted an option, exercisable within 30 days, to purchase up to an additional 375,000 shares of common stock to cover over-allotments, if any, on the same terms and conditions.

On May 7, 2021, DMC issued a total of 2,875,000 shares of its common stock, which included the exercise of the over-allotment option, at a market price of $45 per share resulting in gross proceeds of $129,375. Net proceeds from the offering were $123,461, after deducting underwriter fees and other expenses of $5,914. We intend to use the net proceeds from the offering for general corporate purposes, which may include acquisitions. Pending the use of the proceeds as described, we invested the proceeds of the offering in highly liquid marketable securities, including commercial paper and U.S. Treasury securities. Please see discussion of our marketable securities in Note 2.

At-the-Market Equity Program

On October 22, 2020, the Company commenced an at-the-market ("ATM") equity program under its shelf registration statement, which allows it to sell and issue up to $75 million in shares of its common stock from time to time. The Company entered into an Equity Distribution Agreement on October 22, 2020 with KeyBanc relating to the issuance and sale of shares of common stock pursuant to the program. KeyBanc is not required to sell any specific amount of securities but will act as our sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between KeyBanc and us. There is no specific date on which the ATM equity program will end and there are no minimum purchase requirements. KeyBanc is entitled to compensation for shares sold pursuant to the program in an amount up to 1.5% of the gross proceeds of any shares of common stock sold under the Equity Distribution Agreement.

During the three months ended September 30, 2021, the Company did not sell any shares of common stock through its ATM equity program. During the nine months ended September 30, 2021, the Company sold 397,820 shares of common stock through its ATM equity program for gross proceeds of $25,647 at a weighted average price per share of $64.47. Net proceeds from such sales were $25,262, after deducting commissions paid to the sales agents of approximately $385. Since the inception of the program, the Company has sold 1,006,180 shares of common stock for gross proceeds of $51,779 at a weighted average price per share of $51.46. Total net proceeds from sales through the ATM program have been $51,002. We intend to use the net proceeds from the ATM equity program for general corporate purposes, which may include working capital, debt repayment and potential acquisitions or investments in businesses, products or technologies. Pending the use of the proceeds as described, a portion of the proceeds from the ATM program has been invested in highly liquid marketable securities, including commercial paper and U.S. Treasury securities, while the balance remains in cash. Please see discussion of our marketable securities in Note 2.

XML

INCOME TAXES

9 Months Ended

Sep. 30, 2021

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

The effective tax rate for each of the periods reported differs from the U.S. statutory rate primarily due to variation in contribution to consolidated pre-tax income from each jurisdiction for the respective periods, differences between the U.S. and foreign tax rates (which range from 20% to 34%), permanent differences between book and taxable income, and changes to valuation allowances on our deferred tax assets.

We assess the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use existing deferred tax assets. Additionally, a three-year cumulative loss at a Consolidated Financial Statement level may be viewed as negative evidence impacting a jurisdiction that by itself is not in a three-year cumulative loss position. During the nine months ended September 30, 2021 and September 30, 2020, we did not record any adjustments to previously established valuation allowances, except for adjustments related to the changes in balances of the related deferred tax assets. The Company will continue to monitor the realizability of deferred tax assets and the need for valuation allowances and will record adjustments in the periods in which facts support such adjustments.

The Tax Cuts and Jobs Act (“TCJA”) provides that foreign earnings generally can be repatriated to the U.S. without federal tax consequence. We have assessed the assertion that cumulative earnings by our foreign subsidiaries are indefinitely reinvested. We continue to permanently reinvest the earnings of our international subsidiaries and therefore we do not provide for U.S. income taxes or withholding taxes that could result from the distribution of those earnings to the U.S. parent. Nevertheless, if any such earnings were ultimately distributed to the U.S. in the form of dividends or otherwise, or if the shares of our international subsidiaries were sold or transferred, we could be subject to additional U.S. federal and state income taxes. Due to the multiple avenues in which earnings can be repatriated, and because a large portion of these earnings are not liquid, it is not practical to estimate the amount of additional taxes that might be payable on these amounts of undistributed foreign income.

During the fourth quarter of 2019, our German operating entities commenced a tax audit for fiscal years 2015 through 2017. The audit concluded in the second quarter of 2021, and we recorded additional tax expense of $25 after receiving all material assessments from the German authorities.

XML

BUSINESS SEGMENTS

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

BUSINESS SEGMENTS

BUSINESS SEGMENTS

Our business is organized into two segments: DynaEnergetics and NobelClad. DynaEnergetics designs, manufactures and distributes products utilized by the global oil and gas industry principally for the perforation of oil and gas wells. NobelClad is a global leader in the production of explosion-welded clad metal plates for use in the construction of corrosion resistant industrial processing equipment and specialized transition joints.

Our reportable segments are separately managed strategic business units that offer different products and services. Each segment’s products are marketed to different customer types and require different manufacturing processes and technologies.

Segment information is as follows:

 

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales
DynaEnergetics	$	44,237	$	34,201	$	124,677	$	111,065
NobelClad	22,938		21,080		63,594		60,983
Net sales	$	67,175	$	55,281	$	188,271	$	172,048

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Operating income
DynaEnergetics	$	1,585	$	2,171	$	6,307	$	3,886
NobelClad	3,620		2,483		8,595		5,941
Segment operating income	5,205		4,654		14,902		9,827
Unallocated corporate expenses	(2,499)		(1,594)		(6,903)		(5,851)
Stock-based compensation	(1,569)		(1,595)		(4,904)		(4,154)
Other (expense) income, net	(198)		(148)		304		(118)
Interest expense, net	(14)		(170)		(230)		(564)
Income (loss) before income taxes	$	925	$	1,147	$	3,169	$	(860)

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Depreciation and amortization
DynaEnergetics	$	2,012	$	1,866	$	6,095	$	5,410
NobelClad	967		879		2,851		2,594
Segment depreciation and amortization	2,979		2,745		8,946		8,004
Corporate and other	102		75		277		239
Consolidated depreciation and amortization	$	3,081	$	2,820	$	9,223	$	8,243

The disaggregation of revenue earned from contracts with customers based on the geographic location of the customer is as follows.

DynaEnergetics

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
United States	$	36,453	$	23,324	$	96,316	$	80,931
Canada	2,798		1,856		9,304		2,504
Egypt	671		388		2,398		2,642
Oman	665		1,148		2,117		1,842
Rest of the world	3,650		7,485		14,542		23,146
Total DynaEnergetics	$	44,237	$	34,201	$	124,677	$	111,065

NobelClad

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
United States	$	11,033	$	10,589	$	30,448	$	30,094
Russia	1,519		—		3,586		—
Canada	1,254		1,985		3,985		5,446
Singapore	1,009		32		1,009		857
United Arab Emirates	929		310		2,030		2,930
China	892		1,448		3,775		1,543
Italy	831		301		1,268		685
Germany	761		982		1,539		2,770
Australia	576		587		1,171		1,193
France	509		300		1,929		2,392
Netherlands	507		361		1,628		1,276
Sweden	494		541		676		1,097
Rest of the world	2,624		3,644		10,550		10,700
Total NobelClad	$	22,938	$	21,080	$	63,594	$	60,983

During the three months ended September 30, 2021, one customer in our DynaEnergetics segment accounted for approximately 11% of consolidated net sales. During the three months ended September 30, 2020, one customer in our DynaEnergetics segment accounted for approximately 11% of consolidated net sales. During the nine months ended September 30, 2021 no single customer accounted for greater than 10% of consolidated net sales. During the nine months ended September 30, 2020, one customer in our DynaEnergetics segment accounted for approximately 12% of consolidated net sales. As of September 30, 2021, one customer in our DynaEnergetics segment accounted for approximately 12% of consolidated accounts receivable. As of December 31, 2020 no single customer accounted for greater than 10% of consolidated accounts receivable.

XML

DERIVATIVE INSTRUMENTS

9 Months Ended

Sep. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS

DERIVATIVE INSTRUMENTS

We are exposed to foreign currency exchange risk resulting from fluctuations in exchange rates, primarily the U.S. dollar to euro, the U.S. dollar to Canadian dollar, and, to a lesser extent, other currencies, arising from inter-company and third-party transactions entered into by our subsidiaries that are denominated in currencies other than their functional currency. Changes in exchange rates with respect to these transactions result in unrealized gains or losses if such transactions are unsettled at the end of the reporting period or realized gains or losses at settlement of the transaction. We use foreign currency forward contracts to offset foreign exchange rate fluctuations on foreign currency denominated asset and liability positions. None of these contracts are designated as accounting hedges, and all changes in the fair value of the forward contracts are recognized in “Other (expense) income, net” within our Condensed Consolidated Statements of Operations.

We execute derivatives with a specialized foreign exchange brokerage firm as well as other large financial institutions. The primary credit risk inherent in derivative agreements is the possibility that a loss may occur from the nonperformance of a counterparty to the agreements. We perform a review of the credit risk of our counterparties at the inception of the contract and on an ongoing basis. We anticipate that our counterparties will be able to fully satisfy their obligations under the agreements but will take action if doubt arises regarding the counterparties’ ability to perform.

As of September 30, 2021 and December 31, 2020, the notional amounts of the forward currency contracts the Company held were $11,746 and $2,092, respectively. At September 30, 2021 and December 31, 2020, the fair values of outstanding foreign currency forward contracts were $0.

The following table presents the location and amount of net losses from hedging activities:

		Three months ended September 30,				Nine months ended September 30,
Derivative	Statements of Operations Location	2021		2020		2021		2020
Foreign currency contracts	Other (expense) income, net	$	(253)	$	(1,045)	$	(187)	$	(917)

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

Contingent Liabilities

The Company records an accrual for contingent liabilities when a loss is both probable and reasonably estimable. If some amount within a range of loss appears to be a better estimate than any other amount within the range, that amount is accrued. When no amount within a range of loss appears to be a better estimate than any other amount, the lowest amount in the range is accrued.

Legal Proceedings

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

XML

RESTRUCTURING EXPENSES AND ASSET IMPAIRMENTS

9 Months Ended

Sep. 30, 2021

Restructuring and Related Activities [Abstract]

RESTRUCTURING EXPENSES AND ASSET IMPAIRMENTS

RESTRUCTURING EXPENSES AND ASSET IMPAIRMENTS

During the first quarter of 2021, NobelClad recorded an accrual for additional severance liabilities of $116 which were agreed to with local labor authorities for employees terminated as part of closing manufacturing operations in France in 2018.

During the third quarter of 2020, DynaEnergetics sold its Tyumen, Siberia production facility to a third-party for $448, which was equal to the carrying value of the assets held for sale.

During the second quarter of 2020 the COVID-19 pandemic-related collapse in oil and gas demand led to a downturn in well completions and the corresponding demand for DynaEnergetics’ products. As a result, DynaEnergetics recorded asset impairment charges of $1,181 on certain manufacturing assets that will no longer be utilized in production at its Blum, Texas and Troisdorf, Germany facilities. Additionally, both DynaEnergetics and NobelClad further reduced the respective workforces during the quarter. Finally, DynaEnergetics continued activities to prepare its Tyumen, Siberia facility for sale.

During the first quarter of 2020, DMC reduced its workforce by 264 positions to address a sharp decline in well completions in the Company’s core oil and gas end market principally due to the COVID-19 pandemic. The workforce reduction impacted full-time, part-time and temporary direct-labor roles in manufacturing and assembly at DynaEnergetics as well as general and administrative positions at DynaEnergetics, NobelClad, and at DMC’s corporate office.

Total restructuring and impairment charges incurred for these programs are as follows and are reported in the “Restructuring expenses and asset impairments” line item in our Condensed Consolidated Statements of Operations:

	Nine months ended September 30, 2021
	Severance		Other Exit Costs		Total
NobelClad	$	116	$	11	$	127
Total	$	116	$	11	$	127

	Three months ended September 30, 2020
	Severance		Contract Termination Costs		Other Exit Costs		Total
DynaEnergetics	$	109	$	8	$	16	$	133
NobelClad	—		—		10		10
Total	$	109	$	8	$	26	$	143

	Nine months ended September 30, 2020
	Severance		Asset Impairment		Contract Termination Costs		Equipment Moving Costs		Other Exit Costs		Total
DynaEnergetics	$	936	$	1,181	$	19	$	126	$	660	$	2,922
NobelClad	244		—		—		—		20		264
Corporate	119		—		—		—		—		119
Total	$	1,299	$	1,181	$	19	$	126	$	680	$	3,305

During the nine months ended September 30, 2021, the changes to the restructuring liability associated with these programs is summarized below:

	December 31, 2020		Net expense		Payments and Other Adjustments		Currency Adjustments		September 30, 2021
Severance	$	958	$	116	$	(56)	$	(57)	$	961
Other exit costs	—		11		(11)		—		—
Total	$	958	$	127	$	(67)	$	(57)	$	961

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Principles of Consolidation

Principles of Consolidation

The condensed consolidated financial statements include the accounts of DMC Global Inc. (“DMC”, “we”, “us”, “our”, or the “Company”) and its controlled subsidiaries. Only subsidiaries in which controlling interests are maintained are consolidated. All significant intercompany accounts, profits, and transactions have been eliminated in consolidation.

Marketable Securities

Marketable Securities

We typically invest in highly rated securities with the primary objectives of preserving principal, providing access to liquidity to fund the ongoing operations and strategic needs of the Company and its subsidiaries, and achieving a yield that is commensurate with low risk and highly liquid securities.

Our investments in marketable debt securities are classified as either trading, available-for-sale or held-to-maturity based on the nature of the securities and their availability for use in current operations. The Company classifies its marketable debt securities in the Condensed Consolidated Balance Sheet as current or non-current based on related maturities and expectations of sales and redemptions in the subsequent twelve-month period. The Company may sell certain of its marketable debt securities prior to their stated maturities to manage liquidity, credit risk, or asset allocation.

As of September 30, 2021 and December 31, 2020, our investments had maturities ranging from three to twelve months, and all such investments have been classified and accounted for as trading securities.

The Company’s investments in marketable securities are measured at fair value with gains and losses recognized in the Condensed Consolidated Statement of Operations within “Other (expense) income, net."

Accounts and Notes Receivable

Accounts and Notes Receivable

The Company measures expected credit losses for its accounts receivable using a current expected credit loss model, which is based on historical experience, adjusted for current conditions and reasonable and supportable forecasts. The Company has disaggregated pools of accounts receivable balances by business, geography and/or customer risk profile and has used

history and other experience to establish an allowance for credit losses at the time the receivable is recognized. To measure expected credit losses, we have elected to pool trade receivables by segment and analyze DynaEnergetics and NobelClad accounts receivable balances as separate populations. Within each segment, receivables exhibit similar risk characteristics.

Revenue Recognition

Revenue Recognition

The Company’s revenues are primarily derived from consideration paid by customers for tangible goods. The Company analyzes its different goods by segment to determine the appropriate basis for revenue recognition. Revenue is not generated from sources other than contracts with customers and revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. There are no material upfront costs for operations that are incurred from contracts with customers.

Our rights to payments for goods transferred to customers arise when control is transferred at a point in time and not on any other criteria. Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 60 days. In instances when we require customers to make advance payments prior to the shipment of their orders, we record a contract liability. We have determined that our contract liabilities do not include a significant financing component given the short duration between order initiation and order fulfillment within each of our segments.On occasion, we require customers to make advance payments prior to the shipment of goods in order to help finance our inventory investment on large orders or to keep customers’ credit limits at acceptable levels.

Income Taxes

Income Taxes

We recognize deferred tax assets and liabilities for the expected future income tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities. Any effects of changes in income tax rates or tax laws are included in the provision for income taxes in the period of enactment. The deferred income tax impact of tax credits is recognized as an immediate adjustment to income tax expense. We recognize deferred tax assets for the expected future effects of all deductible temporary differences to the extent we believe these assets will more likely than not be realized. We record a valuation allowance when, based on current circumstances, it is more likely than not that all or a portion of the deferred tax assets will not be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, recent financial operations and their associated valuation allowances, if any.

We recognize the tax benefits from uncertain tax positions only when it is more likely than not, based on the technical merits of the position that it will be sustained upon examination, including the resolution of any related appeals or litigation. The tax benefits recognized in the consolidated financial statements from such a position are measured as the largest benefit that is more likely than not to be realized upon ultimate resolution. We recognize interest and penalties related to uncertain tax positions in operating expense.

Earnings Per Share

Earnings Per Share

In periods with net income, the Company computes earnings per share (“EPS”) using a two-class method, which is an earnings allocation formula that determines EPS for (i) each class of common stock (the Company has a single class of common stock), and (ii) participating securities according to dividends declared and participation rights in undistributed earnings. Restricted stock awards are considered participating securities in periods of net income as they receive non-forfeitable rights to dividends similar to common stock. Restricted stock awards do not participate in net losses.

Basic EPS is calculated by dividing net income available to common stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS adjusts basic EPS for the effects of restricted stock awards, performance share units and other potentially dilutive financial instruments (dilutive securities), only in the periods in which such effect is dilutive. The effect of the dilutive securities is reflected in diluted EPS by application of the more dilutive of (1) the treasury stock method or (2) the two-class method.

Deferred Compensation

Deferred compensation

The Company maintains a Non-Qualified Deferred Compensation Plan (the “Plan”) as part of its overall compensation package for certain employees. Participants are eligible to defer a portion of their annual salary, their annual incentive bonus, and their equity awards through the Plan on a tax-deferred basis. Deferrals into the Plan are not matched or subsidized by the Company, nor are they eligible for above-market or preferential earnings.

The Plan provides for deferred compensation obligations to be settled either by delivery of a fixed number of shares of DMC’s common stock or in cash, in accordance with participant contributions and elections. For deferred equity awards, subsequent to equity award vesting and after a period prescribed by the Plan, participants can elect to diversify contributions of equity awards into other investment options available to Plan participants. Once diversified, contributions of equity awards will be settled by delivery of cash.

The Company has established a grantor trust commonly known as a “rabbi trust” and contributed certain assets to satisfy the future obligations to participants in the Plan. These assets are subject to potential claims of the Company’s general creditors. The assets held in the trust include unvested restricted stock awards (“RSAs”), vested company stock awards, company-owned life insurance (“COLI”) on certain employees, and money market and mutual funds. Unvested RSAs and common stock held by the trust are reflected in the Consolidated Balance Sheets within “Treasury stock, at cost, and company stock held for deferred compensation, at par” at the par value of the common stock or unvested RSAs. These accounts are not adjusted for subsequent changes in the fair value of the common stock. COLI is accounted for at the cash surrender value while money market and mutual funds held by the trust are accounted for at fair value.

Deferred compensation obligations that will be settled in cash are accounted for on an accrual basis in accordance with the terms of the Plan. These obligations are adjusted based on changes in value of the underlying investment options chosen by Plan participants. Deferred compensation obligations that will be settled by delivery of a fixed number of previously vested shares of the Company’s common stock are reflected in the Consolidated Statements of Stockholders’ Equity within “Common stock” at the par value of the common stock or unvested RSAs. These accounts are not adjusted for subsequent changes in the fair value of the common stock.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We are required to use an established hierarchy for fair value measurements based upon the inputs to the valuation and the degree to which they are observable or not observable in the market. The three levels in the hierarchy are as follows:                   

•Level 1 — Inputs to the valuation based upon quoted prices (unadjusted) for identical assets or liabilities in active markets that are accessible as of the measurement date.

•Level 2 — Inputs to the valuation include quoted prices in either markets that are not active, or in active markets for similar assets or liabilities, inputs other than quoted prices that are observable, and inputs that are derived principally from or corroborated by observable market data.

•Level 3 — Inputs to the valuation that are unobservable inputs for the asset or liability. 

The highest priority is assigned to Level 1 inputs and the lowest priority to Level 3 inputs.

The carrying value of accounts receivable and payable, accrued expenses, revolving loans under our credit facility and borrowings under our capital expenditure facility, when outstanding, approximate their fair value.

Our U.S. Treasury marketable securities are valued using quoted prices in active markets that are accessible as of the measurement date. Our revolving loans and borrowings under our capital expenditure facility, when outstanding, reset each month at market interest rates. Money market funds and mutual funds of $8,629 as of September 30, 2021 and $4,244 as of December 31, 2020 held to satisfy future deferred compensation obligations are valued based upon the market values of underlying securities. We classify these assets as Level 1 in the fair value hierarchy.

Our commercial paper marketable securities are valued using quoted market prices in non-active markets. Our foreign currency forward contracts are also valued using quoted market prices in non-active markets or are determined using a yield curve model based on current market rates. As a result, we classify commercial paper marketable securities and foreign currency forward contracts as Level 2 in the fair value hierarchy.

Recent Accounting Pronouncements

Recent Accounting PronouncementsIn December 2019, the Financial Accounting Standards Board issued a new accounting pronouncement regarding accounting for income taxes. The new standard removes certain exceptions to the general principles in ASC 740 Income Taxes and also clarifies and amends existing guidance to provide for more consistent application. The new standard became effective for the Company in the first quarter of fiscal 2021 and did not have a material impact on our consolidated financial statements.

Inventories

Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Significant cost elements included in inventory are material, labor, freight, subcontract costs, and manufacturing overhead. As necessary, we adjust inventory to its net realizable value by recording provisions for excess, slow moving and obsolete inventory. We regularly review inventory quantities on hand and values, and compare them to estimates of future product demand, market conditions, production requirements and technological developments.

XML

SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Schedule of Marketable Securities

The Company’s investments in marketable securities consisted of the following:

	September 30, 2021		December 31, 2020
U.S. Treasury securities	$	76,591	$	25,736
Commercial paper (A-1 or P-1 rated)	68,341		—
Marketable securities	$	144,932	$	25,736

Schedule of Allowance for Credit Losses on Receivables

The following table summarizes year-to-date activity in the allowance for credit losses on receivables from DynaEnergetics and NobelClad customers:

	DynaEnergetics		NobelClad		DMC Global Inc.
Allowance for doubtful accounts, December 31, 2020	$	2,590	$	15	$	2,605
Current period provision for expected credit losses	100		—		100
Recoveries of amounts previously reserved	(10)		—		(10)
Impacts of foreign currency exchange rates and other	(2)		—		(2)
Allowance for doubtful accounts, September 30, 2021	$	2,678	$	15	$	2,693

During the third quarter of 2021, the Company entered into a note receivable with terms of repayment over five years, collateralized by certain fixed assets. The note, with an outstanding current balance of $622 as of September 30, 2021 recorded within “Prepaid expenses and other” and an outstanding long-term balance of $4,995 as of September 30, 2021 recorded within “Other Assets”, is considered an arrangement with a variable interest entity for which the Company is not the primary beneficiary and has concluded does not require consolidation.

Schedule of Computation and Reconciliation of Earnings Per Common Share

For the periods presented, diluted EPS using the treasury stock method was less dilutive than the two-class method; as such, only the two-class method has been included below.

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net income (loss), as reported	$	403	$	1,008	2,559		(485)
Less: Undistributed net income available to participating securities	(3)		(17)		(25)		—
Numerator for basic net income (loss) per share:	400		991		2,534		(485)
Add: Undistributed net income allocated to participating securities	3		17		25		—
Less: Undistributed net income reallocated to participating securities	(3)		(17)		(25)		—
Numerator for diluted net income (loss) per share:	400		991		2,534		(485)
Denominator:
Weighted average shares outstanding for basic net income (loss) per share	18,728,278		14,820,881		17,239,306		14,759,062
Effect of dilutive securities (1)	10,807		—		11,219		—
Weighted average shares outstanding for diluted net income (loss) per share	18,739,085		14,820,881		17,250,525		14,759,062
Net income (loss) per share
Basic	$	0.02	$	0.07	$	0.15	$	(0.03)
Diluted	$	0.02	$	0.07	$	0.15	$	(0.03)

(1) For the three and nine months ended September 30, 2020, 30,967 and 19,394 respectively, shares have been excluded as their effect would have been anti-dilutive.

Schedule of Defined Compensation Plan

The balances related to the deferred compensation plan were as follows:

	Consolidated Balance Sheet location	September 30, 2021		December 31, 2020
Deferred compensation assets	Other assets	$	13,261	$	7,596
Deferred compensation obligations	Other long-term liabilities	$	15,695	$	11,894

XML

INVENTORIES (Tables)

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

Schedule of Components of Inventory

Inventories consisted of the following at September 30, 2021:

	DynaEnergetics		NobelClad		DMC Global Inc.
Raw materials	$	13,865	$	8,923	$	22,788
Work-in-process	13,486		6,808		20,294
Finished goods	18,251		634		18,885
Supplies	—		205		205
Inventories	$	45,602	$	16,570	$	62,172

Inventories consisted of the following at December 31, 2020:

	DynaEnergetics		NobelClad		DMC Global Inc.
Raw materials	$	13,250	$	11,903	$	25,153
Work-in-process	7,062		6,682		13,744
Finished goods	12,806		669		13,475
Supplies	—		201		201
Inventories	$	33,118	$	19,455	$	52,573

XML

PURCHASED INTANGIBLE ASSETS (Tables)

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Purchased Intangible Assets, Other Than Goodwill

Our purchased intangible assets consisted of the following as of September 30, 2021:

	Gross		Accumulated Amortization		Net
Core technology	$	16,052	$	(14,223)	$	1,829
Customer relationships	36,110		(36,110)		—
Trademarks / Trade names	2,069		(2,069)		—
Total intangible assets	$	54,231	$	(52,402)	$	1,829

Our purchased intangible assets consisted of the following as of December 31, 2020:

	Gross		Accumulated Amortization		Net
Core technology	$	17,899	$	(14,234)	$	3,665
Customer relationships	37,638		(37,638)		—
Trademarks / Trade names	2,194		(2,194)		—
Total intangible assets	$	57,731	$	(54,066)	$	3,665

XML

CONTRACT LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Contract Liabilities

Contract liabilities were as follows:

	September 30, 2021		December 31, 2020
NobelClad	$	9,450	$	4,450
DynaEnergetics	309		478
Total	$	9,759	$	4,928

XML

LEASES (Tables)

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

Schedule of Operating Lease Assets and Liabilities

Nearly all of the Company’s leasing arrangements are classified as operating leases. ROU asset and lease liability balances were as follows for the periods presented:

	September 30, 2021		December 31, 2020
ROU asset	$	11,198	$	10,733
Current lease liability	1,648		1,741
Long-term lease liability	10,432		10,066
Total lease liability	$	12,080	$	11,807

Schedule of Operating Lease, Supplemental Disclosures

The following table summarizes the weighted average lease terms and discount rates for operating lease liabilities:

	September 30, 2021
Weighted average remaining lease term (in years)	7.71
Weighted average discount rate	5.4	%

Schedule of Operating Lease, Liability, Maturity

The following table represents maturities of operating lease liabilities as of September 30, 2021:

Due within 1 year	$	1,648
Due after 1 year through 2 years	2,379
Due after 2 years through 3 years	2,160
Due after 3 years through 4 years	2,019
Due after 4 years through 5 years	1,642
Due after 5 years	5,067
Total future minimum lease payments	14,915
Less imputed interest	(2,835)
Total	$	12,080

XML

DEBT (Tables)

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Schedule of Lines of Credit

As of December 31, 2020, outstanding borrowings consisted of the following:

Syndicated credit agreement:
Capital expenditure facility	$	11,750
Outstanding borrowings	11,750
Less: debt issuance costs	(486)
Total debt	11,264
Less: current portion of long-term debt	(3,125)
Long-term debt	$	8,139

XML

BUSINESS SEGMENTS (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Schedule of Segment Information

Segment information is as follows:

 

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales
DynaEnergetics	$	44,237	$	34,201	$	124,677	$	111,065
NobelClad	22,938		21,080		63,594		60,983
Net sales	$	67,175	$	55,281	$	188,271	$	172,048

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Operating income
DynaEnergetics	$	1,585	$	2,171	$	6,307	$	3,886
NobelClad	3,620		2,483		8,595		5,941
Segment operating income	5,205		4,654		14,902		9,827
Unallocated corporate expenses	(2,499)		(1,594)		(6,903)		(5,851)
Stock-based compensation	(1,569)		(1,595)		(4,904)		(4,154)
Other (expense) income, net	(198)		(148)		304		(118)
Interest expense, net	(14)		(170)		(230)		(564)
Income (loss) before income taxes	$	925	$	1,147	$	3,169	$	(860)

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Depreciation and amortization
DynaEnergetics	$	2,012	$	1,866	$	6,095	$	5,410
NobelClad	967		879		2,851		2,594
Segment depreciation and amortization	2,979		2,745		8,946		8,004
Corporate and other	102		75		277		239
Consolidated depreciation and amortization	$	3,081	$	2,820	$	9,223	$	8,243

Disaggregation of Revenue

The disaggregation of revenue earned from contracts with customers based on the geographic location of the customer is as follows.

DynaEnergetics

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
United States	$	36,453	$	23,324	$	96,316	$	80,931
Canada	2,798		1,856		9,304		2,504
Egypt	671		388		2,398		2,642
Oman	665		1,148		2,117		1,842
Rest of the world	3,650		7,485		14,542		23,146
Total DynaEnergetics	$	44,237	$	34,201	$	124,677	$	111,065

NobelClad

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
United States	$	11,033	$	10,589	$	30,448	$	30,094
Russia	1,519		—		3,586		—
Canada	1,254		1,985		3,985		5,446
Singapore	1,009		32		1,009		857
United Arab Emirates	929		310		2,030		2,930
China	892		1,448		3,775		1,543
Italy	831		301		1,268		685
Germany	761		982		1,539		2,770
Australia	576		587		1,171		1,193
France	509		300		1,929		2,392
Netherlands	507		361		1,628		1,276
Sweden	494		541		676		1,097
Rest of the world	2,624		3,644		10,550		10,700
Total NobelClad	$	22,938	$	21,080	$	63,594	$	60,983

XML

DERIVATIVE INSTRUMENTS (Tables)

9 Months Ended

Sep. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments, Gain (Loss)

The following table presents the location and amount of net losses from hedging activities:

		Three months ended September 30,				Nine months ended September 30,
Derivative	Statements of Operations Location	2021		2020		2021		2020
Foreign currency contracts	Other (expense) income, net	$	(253)	$	(1,045)	$	(187)	$	(917)

XML

RESTRUCTURING EXPENSES AND ASSET IMPAIRMENTS (Tables)

9 Months Ended

Sep. 30, 2021

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Impairment Charges Incurred

Total restructuring and impairment charges incurred for these programs are as follows and are reported in the “Restructuring expenses and asset impairments” line item in our Condensed Consolidated Statements of Operations:

	Nine months ended September 30, 2021
	Severance		Other Exit Costs		Total
NobelClad	$	116	$	11	$	127
Total	$	116	$	11	$	127

	Three months ended September 30, 2020
	Severance		Contract Termination Costs		Other Exit Costs		Total
DynaEnergetics	$	109	$	8	$	16	$	133
NobelClad	—		—		10		10
Total	$	109	$	8	$	26	$	143

	Nine months ended September 30, 2020
	Severance		Asset Impairment		Contract Termination Costs		Equipment Moving Costs		Other Exit Costs		Total
DynaEnergetics	$	936	$	1,181	$	19	$	126	$	660	$	2,922
NobelClad	244		—		—		—		20		264
Corporate	119		—		—		—		—		119
Total	$	1,299	$	1,181	$	19	$	126	$	680	$	3,305

Schedule of Changes to the Restructuring Liability

During the nine months ended September 30, 2021, the changes to the restructuring liability associated with these programs is summarized below:

	December 31, 2020		Net expense		Payments and Other Adjustments		Currency Adjustments		September 30, 2021
Severance	$	958	$	116	$	(56)	$	(57)	$	961
Other exit costs	—		11		(11)		—		—
Total	$	958	$	127	$	(67)	$	(57)	$	961

XML

SIGNIFICANT ACCOUNTING POLICIES - Marketable Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Marketable Securities [Line Items]
Marketable securities	$ 144,932	$ 25,736
U.S. Treasury securities
Marketable Securities [Line Items]
Marketable securities	76,591	25,736
Commercial paper (A-1 or P-1 rated)
Marketable Securities [Line Items]
Marketable securities	$ 68,341	$ 0

XML

SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2020
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Net gains on marketable securities	$ 2	$ 12
Provision for expected credit losses	4	100
Deferred compensation, mutual funds held by the trust	$ 13,261	$ 13,261	$ 7,596
Variable Interest Entity
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Notes receivable, term	5 years	5 years
Notes receivable, current	$ 622	$ 622
Notes receivable, noncurrent	4,995	4,995
Level 1
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Deferred compensation, mutual funds held by the trust	$ 8,629	$ 8,629	$ 4,244
Minimum
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Payment terms, period		30 days
Minimum | U.S. Treasury securities
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Marketable securities annual yield		0.01%
Minimum | Commercial paper (A-1 or P-1 rated)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Marketable securities annual yield		0.09%
Maximum
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Payment terms, period		60 days
Maximum | U.S. Treasury securities
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Marketable securities annual yield		0.04%
Maximum | Commercial paper (A-1 or P-1 rated)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Marketable securities annual yield		0.10%

XML

SIGNIFICANT ACCOUNTING POLICIES - Rollforward of Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for doubtful accounts, December 31, 2020		$ 2,605
Current period provision for expected credit losses	$ 4	100
Recoveries of amounts previously reserved		(10)
Impacts of foreign currency exchange rates and other		(2)
Allowance for doubtful accounts, September 30, 2021	2,693	2,693
DynaEnergetics
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for doubtful accounts, December 31, 2020		2,590
Current period provision for expected credit losses		100
Recoveries of amounts previously reserved		(10)
Impacts of foreign currency exchange rates and other		(2)
Allowance for doubtful accounts, September 30, 2021	2,678	2,678
NobelClad
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for doubtful accounts, December 31, 2020		15
Current period provision for expected credit losses		0
Recoveries of amounts previously reserved		0
Impacts of foreign currency exchange rates and other		0
Allowance for doubtful accounts, September 30, 2021	$ 15	$ 15

XML

SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share Reconciliation [Abstract]
Net income (loss), as reported	$ 403	$ 1,008	$ 2,559	$ (485)
Less: Undistributed net income available to participating securities	(3)	(17)	(25)	0
Numerator for basic net income (loss) per share:	400	991	2,534	(485)
Add: Undistributed net income allocated to participating securities	3	17	25	0
Less: Undistributed net income reallocated to participating securities	(3)	(17)	(25)	0
Numerator for diluted net income (loss) per share:	$ 400	$ 991	$ 2,534	$ (485)
Denominator:
Weighted average shares outstanding for basic net income (loss) per share (in shares)	18,728,278	14,820,881	17,239,306	14,759,062
Effect of dilutive securities (in shares)	10,807	0	11,219	0
Weighted average shares outstanding for diluted net income (loss) per share (in shares)	18,739,085	14,820,881	17,250,525	14,759,062
Net income (loss) per share
Basic (in dollars per share)	$ 0.02	$ 0.07	$ 0.15	$ (0.03)
Diluted (in dollars per share)	$ 0.02	$ 0.07	$ 0.15	$ (0.03)
Anti-dilutive securities (in shares)		30,967		19,394

XML

SIGNIFICANT ACCOUNTING POLICIES - Deferred Compensation Plan (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Deferred compensation assets	$ 13,261	$ 7,596
Deferred compensation obligations	$ 15,695	$ 11,894

XML

INVENTORIES (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Inventory [Line Items]
Raw materials	$ 22,788	$ 25,153
Work-in-process	20,294	13,744
Finished goods	18,885	13,475
Supplies	205	201
Inventories	62,172	52,573
DynaEnergetics
Inventory [Line Items]
Raw materials	13,865	13,250
Work-in-process	13,486	7,062
Finished goods	18,251	12,806
Supplies	0	0
Inventories	45,602	33,118
NobelClad
Inventory [Line Items]
Raw materials	8,923	11,903
Work-in-process	6,808	6,682
Finished goods	634	669
Supplies	205	201
Inventories	$ 16,570	$ 19,455

XML

PURCHASED INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Purchased intangible assets
Gross	$ 54,231	$ 57,731
Accumulated Amortization	(52,402)	(54,066)
Net	1,829	3,665
Core technology
Purchased intangible assets
Gross	16,052	17,899
Accumulated Amortization	(14,223)	(14,234)
Net	1,829	3,665
Customer relationships
Purchased intangible assets
Gross	36,110	37,638
Accumulated Amortization	(36,110)	(37,638)
Net	0	0
Trademarks / Trade names
Purchased intangible assets
Gross	2,069	2,194
Accumulated Amortization	(2,069)	(2,194)
Net	$ 0	$ 0

XML

CONTRACT LIABILITIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Sep. 30, 2021
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Contract liabilities	$ 4,928	$ 9,759
Percentage of contract liabilities recorded to net sales	78.00%
NobelClad
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Contract liabilities	$ 4,450	9,450
DynaEnergetics
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Contract liabilities	$ 478	$ 309

XML

LEASES - ROU Asset and Lease Liability Balances (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
ROU asset	$ 11,198	$ 10,733
Current lease liability	1,648	1,741
Long-term lease liability	10,432	10,066
Total lease liability	$ 12,080	$ 11,807

XML

LEASES - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Leases [Abstract]
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets		Other assets		Other assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other current liabilities		Other current liabilities		Other current liabilities
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other long-term liabilities		Other long-term liabilities		Other long-term liabilities
Operating lease cost	$ 1,064	$ 1,055	$ 3,074	$ 3,051
Lease renewal option	5 years		5 years

XML

LEASES - Weighted Average Lease Terms and Discount Rates (Details)	Sep. 30, 2021
Leases [Abstract]
Weighted average remaining lease term (in years)	7 years 8 months 15 days
Weighted average discount rate	5.40%

XML

LEASES - Maturities of Operating Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
Due within 1 year	$ 1,648
Due after 1 year through 2 years	2,379
Due after 2 years through 3 years	2,160
Due after 3 years through 4 years	2,019
Due after 4 years through 5 years	1,642
Due after 5 years	5,067
Total future minimum lease payments	14,915
Less imputed interest	(2,835)
Total	$ 12,080	$ 11,807

XML

DEBT - Narrative (Details)		1 Months Ended	9 Months Ended
	Mar. 08, 2018 USD ($) bank	Feb. 28, 2021 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 EUR (€)	Dec. 31, 2020 USD ($)	Oct. 22, 2020 USD ($)	Jul. 31, 2020 EUR (€)	Jun. 30, 2020 EUR (€)
Debt Instrument [Line Items]
Outstanding borrowings						$ 11,750,000
Credit agreement, number of banks | bank	3
Amortization of principal, percent	12.50%
Repayments on capital expenditure facility			$ 11,750,000	$ 2,344,000
Maximum amount of shares authorized to sell							$ 75,000,000
Long-term debt			0			11,264,000
Debt issuance costs			318,000			486,000
Capital expenditure facility
Debt Instrument [Line Items]
Outstanding borrowings						$ 11,750,000
Credit Facility
Debt Instrument [Line Items]
Outstanding borrowings			$ 0
Credit Facility | Syndicated Credit Facility 2018
Debt Instrument [Line Items]
Credit facility, term	5 years
Maximum borrowing capacity	$ 75,000,000
Accordion feature	100,000,000
Credit Facility | U.S. Dollar revolving loan
Debt Instrument [Line Items]
Maximum borrowing capacity	50,000,000
Credit Facility | Alternate Currencies Revolving Loan
Debt Instrument [Line Items]
Maximum borrowing capacity	20,000,000
Credit Facility | Alternate Currencies Revolving Loan | Minimum | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable interest rate			1.50%
Credit Facility | Alternate Currencies Revolving Loan | Minimum | Base Rate
Debt Instrument [Line Items]
Basis spread on variable interest rate			0.50%
Credit Facility | Alternate Currencies Revolving Loan | Maximum | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable interest rate			3.00%
Credit Facility | Alternate Currencies Revolving Loan | Maximum | Base Rate
Debt Instrument [Line Items]
Basis spread on variable interest rate			2.00%
Credit Facility | Capital expenditure facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 25,000,000
Repayments on capital expenditure facility		$ 11,750,000
Credit Facility | German Bank Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity | €								€ 7,000,000	€ 4,000,000
Available borrowing capacity | €					€ 4,000,000

XML

DEBT - Schedule of Debt (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Outstanding borrowings		$ 11,750,000
Less: debt issuance costs	$ (318,000)	(486,000)
Total debt	0	11,264,000
Less: current portion of long-term debt	$ 0	(3,125,000)
Long-term debt		8,139,000
Capital expenditure facility
Debt Instrument [Line Items]
Outstanding borrowings		$ 11,750,000

XML

EQUITY OFFERINGS AND PROGRAM - Narrative (Details) - USD ($)				3 Months Ended	9 Months Ended	11 Months Ended
	May 07, 2021	May 03, 2021	Oct. 22, 2020	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Common stock, par value (in dollars per share)				$ 0.05	$ 0.05	$ 0.05	$ 0.05
Maximum amount of shares authorized to sell			$ 75,000,000
Equity Offering
Subsidiary, Sale of Stock [Line Items]
Number of shares agreed upon to sell (in shares)		2,500,000
Common stock, par value (in dollars per share)		$ 0.05
Sale of stock, number of shares issued in transaction (in shares)	2,875,000
Sale of stock, price (in dollars per share)	$ 45
Gross proceeds	$ 129,375,000
Sale of stock, net consideration received	123,461,000
Commissions paid	$ 5,914,000
Over-Allotment Option
Subsidiary, Sale of Stock [Line Items]
Number of shares agreed upon to sell (in shares)		375,000
Sale of stock, transaction period		30 days
ATM Offering
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued in transaction (in shares)				0	397,820	1,006,180
Gross proceeds					$ 25,647,000	$ 51,779,000
Sale of stock, net consideration received					25,262,000	$ 51,002,000
Commissions paid					$ 385,000
Maximum amount of shares authorized to sell			$ 75,000,000
Agent fee, percentage			1.50%
Weighted average price per share (in dollars per share)					$ 64.47	$ 51.46

XML

INCOME TAXES (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jun. 30, 2021	Sep. 30, 2021
Operating Loss Carryforwards [Line Items]
Additional tax expense	$ 25
Minimum
Operating Loss Carryforwards [Line Items]
Differences between U.S. and foreign tax rates, range		20.00%
Maximum
Operating Loss Carryforwards [Line Items]
Differences between U.S. and foreign tax rates, range		34.00%

XML

BUSINESS SEGMENTS - Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) segment	Sep. 30, 2020 USD ($)
Segment information
Number of segments | segment			2
Net sales	$ 67,175	$ 55,281	$ 188,271	$ 172,048
Segment operating income	1,137	1,465	3,095	(178)
Other (expense) income, net	(198)	(148)	304	(118)
Interest expense, net	(14)	(170)	(230)	(564)
Income (loss) before income taxes	925	1,147	3,169	(860)
Depreciation and amortization	3,081	2,820	9,223	8,243
Operating Segments
Segment information
Segment operating income	5,205	4,654	14,902	9,827
Depreciation and amortization	2,979	2,745	8,946	8,004
Segment Reconciling Items
Segment information
Unallocated corporate expenses	(2,499)	(1,594)	(6,903)	(5,851)
Stock-based compensation	(1,569)	(1,595)	(4,904)	(4,154)
Other (expense) income, net	(198)	(148)	304	(118)
Interest expense, net	(14)	(170)	(230)	(564)
Corporate and other
Segment information
Depreciation and amortization	102	75	277	239
DynaEnergetics
Segment information
Net sales	44,237	34,201	124,677	111,065
DynaEnergetics | Operating Segments
Segment information
Segment operating income	1,585	2,171	6,307	3,886
Depreciation and amortization	2,012	1,866	6,095	5,410
NobelClad
Segment information
Net sales	22,938	21,080	63,594	60,983
NobelClad | Operating Segments
Segment information
Segment operating income	3,620	2,483	8,595	5,941
Depreciation and amortization	$ 967	$ 879	$ 2,851	$ 2,594

XML

BUSINESS SEGMENTS - Disaggregation of Revenue by Geographic Location (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Net sales	$ 67,175	$ 55,281	$ 188,271	$ 172,048
DynaEnergetics
Disaggregation of Revenue [Line Items]
Net sales	$ 44,237	$ 34,201	$ 124,677	$ 111,065
DynaEnergetics | Customer Concentration Risk | Revenue from Contract with Customer Benchmark | One Customer
Disaggregation of Revenue [Line Items]
Concentration risk percentage	11.00%	11.00%		12.00%
DynaEnergetics | Customer Concentration Risk | Accounts Receivable | One Customer
Disaggregation of Revenue [Line Items]
Concentration risk percentage			12.00%
DynaEnergetics | United States
Disaggregation of Revenue [Line Items]
Net sales	$ 36,453	$ 23,324	$ 96,316	$ 80,931
DynaEnergetics | Canada
Disaggregation of Revenue [Line Items]
Net sales	2,798	1,856	9,304	2,504
DynaEnergetics | Egypt
Disaggregation of Revenue [Line Items]
Net sales	671	388	2,398	2,642
DynaEnergetics | Oman
Disaggregation of Revenue [Line Items]
Net sales	665	1,148	2,117	1,842
DynaEnergetics | Rest of the world
Disaggregation of Revenue [Line Items]
Net sales	3,650	7,485	14,542	23,146
NobelClad
Disaggregation of Revenue [Line Items]
Net sales	22,938	21,080	63,594	60,983
NobelClad | United States
Disaggregation of Revenue [Line Items]
Net sales	11,033	10,589	30,448	30,094
NobelClad | Canada
Disaggregation of Revenue [Line Items]
Net sales	1,254	1,985	3,985	5,446
NobelClad | Rest of the world
Disaggregation of Revenue [Line Items]
Net sales	2,624	3,644	10,550	10,700
NobelClad | Russia
Disaggregation of Revenue [Line Items]
Net sales	1,519	0	3,586	0
NobelClad | Singapore
Disaggregation of Revenue [Line Items]
Net sales	1,009	32	1,009	857
NobelClad | United Arab Emirates
Disaggregation of Revenue [Line Items]
Net sales	929	310	2,030	2,930
NobelClad | China
Disaggregation of Revenue [Line Items]
Net sales	892	1,448	3,775	1,543
NobelClad | Italy
Disaggregation of Revenue [Line Items]
Net sales	831	301	1,268	685
NobelClad | Germany
Disaggregation of Revenue [Line Items]
Net sales	761	982	1,539	2,770
NobelClad | Australia
Disaggregation of Revenue [Line Items]
Net sales	576	587	1,171	1,193
NobelClad | France
Disaggregation of Revenue [Line Items]
Net sales	509	300	1,929	2,392
NobelClad | Netherlands
Disaggregation of Revenue [Line Items]
Net sales	507	361	1,628	1,276
NobelClad | Sweden
Disaggregation of Revenue [Line Items]
Net sales	$ 494	$ 541	$ 676	$ 1,097

XML

DERIVATIVE INSTRUMENTS - Narrative (Details) - Foreign Exchange Forward - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Derivatives, Fair Value [Line Items]
Notional amounts	$ 11,746,000	$ 2,092,000
Fair value of outstanding foreign currency forward	$ 0	$ 0

XML

DERIVATIVE INSTRUMENTS - Gain/(Loss) Recognized in Income on Derivatives (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Foreign currency contracts | Other (expense) income, net
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on foreign currency contracts	$ (253)	$ (1,045)	$ (187)	$ (917)

XML

RESTRUCTURING EXPENSES AND ASSET IMPAIRMENTS - Narrative (Details) $ in Thousands	3 Months Ended					9 Months Ended
	Sep. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Sep. 30, 2020 USD ($)	Jun. 30, 2020 USD ($)	Mar. 31, 2020 employee	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments	$ 0		$ 143			$ 127	$ 3,305
Carrying value of assets held for sale			448
Number of positions eliminated | employee					264
NobelClad
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						127
Severance
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			$ 109			116	1,299
Severance | NobelClad
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments		$ 116				$ 116
Asset Impairment
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments							$ 1,181
Asset Impairment | DynaEnergetics
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments				$ 1,181

XML

RESTRUCTURING EXPENSES AND ASSET IMPAIRMENTS - Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments	$ 0		$ 143		$ 127	$ 3,305
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						119
DynaEnergetics | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			133			2,922
NobelClad
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments					127
NobelClad | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			10			264
Severance
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			109		116	1,299
Severance | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						119
Severance | DynaEnergetics | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			109			936
Severance | NobelClad
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments		$ 116			116
Severance | NobelClad | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			0			244
Asset Impairment
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						1,181
Asset Impairment | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						0
Asset Impairment | DynaEnergetics
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments				$ 1,181
Asset Impairment | DynaEnergetics | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						1,181
Asset Impairment | NobelClad | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						0
Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			8			19
Contract Termination Costs | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						0
Contract Termination Costs | DynaEnergetics | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			8			19
Contract Termination Costs | NobelClad | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			0			0
Equipment Moving Costs
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						126
Equipment Moving Costs | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						0
Equipment Moving Costs | DynaEnergetics | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						126
Equipment Moving Costs | NobelClad | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						0
Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			26		11	680
Other Exit Costs | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments						0
Other Exit Costs | DynaEnergetics | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			16			660
Other Exit Costs | NobelClad
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments					$ 11
Other Exit Costs | NobelClad | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring expenses and asset impairments			$ 10			$ 20

XML

RESTRUCTURING EXPENSES AND ASSET IMPAIRMENTS - Rollforward of Restructuring Charges (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($)
Restructuring Reserve [Roll Forward]
December 31, 2020	$ 958
Net expense	127
Payments and Other Adjustments	(67)
Currency Adjustments	(57)
September 30, 2021	961
Severance
Restructuring Reserve [Roll Forward]
December 31, 2020	958
Net expense	116
Payments and Other Adjustments	(56)
Currency Adjustments	(57)
September 30, 2021	961
Other exit costs
Restructuring Reserve [Roll Forward]
December 31, 2020	0
Net expense	11
Payments and Other Adjustments	(11)
Currency Adjustments	0
September 30, 2021	$ 0

XML

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2016-13 [Member]